Constitutive	O
activation	O
of	O
an	O
epithelial	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
STAT	B-protein
)	O
pathway	O
in	O
asthma	O
.	O

Cytokine	B-protein
effects	O
on	O
immunity	O
and	O
inflammation	O
often	O
depend	O
on	O
the	O
transcription	B-protein
factors	I-protein
termed	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
(	O
STATs	B-protein
)	O
,	O
so	O
STAT	B-protein
signaling	O
pathways	O
are	O
candidates	O
for	O
influencing	O
inflammatory	O
disease	O
.	O

We	O
reasoned	O
that	O
selective	O
IFN	B-protein
responsiveness	O
of	O
the	O
first	O
STAT	B-protein
family	I-protein
member	I-protein
(	O
Stat1	B-protein
)	O
and	O
Stat1-dependent	B-DNA
immune-response	I-DNA
genes	I-DNA
such	O
as	O
intercellular	B-protein
adhesion	I-protein
molecule-1	I-protein
(	O
ICAM-1	B-protein
)	O
,	O
IFN	B-protein
regulatory	I-protein
factor-1	I-protein
(	O
IRF-1	B-protein
)	O
,	O
and	O
Stat1	B-protein
itself	O
in	O
airway	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
provides	O
a	O
basis	O
for	O
detecting	O
cytokine	B-protein
signaling	O
abnormalities	O
in	O
inflammatory	O
airway	O
disease	O
.	O

On	O
the	O
basis	O
of	O
nuclear	O
localization	O
and	O
phosphorylation	O
,	O
we	O
found	O
that	O
epithelial	B-protein
Stat1	I-protein
(	O
but	O
not	O
other	O
control	O
transcription	B-protein
factors	I-protein
)	O
was	O
invariably	O
activated	O
in	O
asthmatic	O
compared	O
with	O
normal	O
control	O
or	O
chronic	O
bronchitis	O
subjects	O
.	O

Furthermore	O
,	O
epithelial	O
levels	O
of	O
activated	O
Stat1	B-protein
correlated	O
with	O
levels	O
of	O
expression	O
for	O
epithelial	B-protein
ICAM-1	I-protein
,	O
IRF-1	B-protein
,	O
and	O
Stat1	B-protein
,	O
and	O
in	O
turn	O
,	O
ICAM-1	B-protein
levels	O
correlated	O
with	O
T-cell	O
accumulation	O
in	O
tissue	O
.	O

However	O
,	O
only	O
low	O
levels	O
of	O
IFN-gamma	B-protein
or	O
IFN-gamma-producing	B-cell_type
cells	I-cell_type
were	O
detected	O
in	O
airway	O
tissue	O
in	O
all	O
subjects	O
.	O

The	O
results	O
therefore	O
provide	O
initial	O
evidence	O
linking	O
abnormal	O
behavior	O
of	O
STAT	B-protein
pathways	O
for	O
cytokine	B-protein
signaling	O
to	O
the	O
development	O
of	O
an	O
inflammatory	O
disease	O
.	O

In	O
that	O
context	O
,	O
the	O
results	O
also	O
change	O
the	O
current	O
scheme	O
for	O
asthma	O
pathogenesis	O
to	O
one	O
that	O
must	O
include	O
a	O
localized	O
gain	O
in	O
transcriptional	O
signal	O
ordinarily	O
used	O
for	O
a	O
T	B-protein
helper	I-protein
1-type	I-protein
cytokine	I-protein
(	O
IFN-gamma	B-protein
)	O
in	O
combination	O
with	O
allergy-driven	O
overproduction	O
of	O
T	B-protein
helper	I-protein
2-type	I-protein
cytokines	I-protein
.	O

Constitutive	NULL
activation	NULL
of	NULL
an	NULL
epithelial	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
pathway	NULL
in	NULL
asthma	NULL
Deepak	NULL
Sampath	NULL
,	NULL
'	NULL
Mario	NULL
Castro	NULL
,	NULL
!	NULL

Dwight	NULL
C.	NULL
Look	NULL
,	NULL
!	NULL

and	NULL
Michael	NULL
J.	NULL
Holtzman	NULL
!	NULL

'Department	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
*Department	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
,	NULL
USA	NULL
Address	NULL
correspondence	NULL
to	NULL
:	NULL
M.J.	NULL
Holtzman	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Campus	NULL
Box	NULL
8052	NULL
,	NULL
660	NULL
South	NULL
Euclid	NULL
Avenue	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
,	NULL
USA	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
314	NULL
)	NULL
362-8970	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
314	NULL
)	NULL
362-8987	NULL
;	NULL
E-mail	NULL
:	NULL
mholtzman	NULL
@	NULL
pulmonary.wustl.edu	NULL
Received	NULL
for	NULL
publication	NULL
December	NULL
22	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
March	NULL
23	NULL
,	NULL
1999	NULL
.	NULL

Cytokine	NULL
effects	NULL
on	NULL
immunity	NULL
and	NULL
inflammation	NULL
often	NULL
depend	NULL
on	NULL
the	NULL
transcription	NULL
factors	NULL
termed	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
's	NULL
)	NULL
,	NULL
so	NULL
STAT	NULL
signaling	NULL
pathways	NULL
are	NULL
candidates	NULL
for	NULL
influencing	NULL
inflammatory	NULL
disease	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
selective	NULL
IFN	NULL
responsiveness	NULL
of	NULL
the	NULL
first	NULL
STAT	NULL
family	NULL
member	NULL
(	NULL
Stat1	NULL
)	NULL
and	NULL
Stat1-dependent	NULL
immune-response	NULL
genes	NULL
such	NULL
as	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
,	NULL
IFN	NULL
regulatory	NULL
factor-1	NULL
(	NULL
IRF-1	NULL
)	NULL
,	NULL
and	NULL
Stat1	NULL
itself	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
provides	NULL
a	NULL
basis	NULL
for	NULL
detecting	NULL
cytokine	NULL
signaling	NULL
abnormalities	NULL
in	NULL
inflammatory	NULL
airway	NULL
disease	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
nuclear	NULL
localization	NULL
and	NULL
phosphorylation	NULL
,	NULL
we	NULL
found	NULL
that	NULL
epithelial	NULL
Stat1	NULL
(	NULL
but	NULL
not	NULL
other	NULL
control	NULL
transcription	NULL
factors	NULL
)	NULL
was	NULL
invariably	NULL
activated	NULL
in	NULL
asthmatic	NULL
compared	NULL
with	NULL
normal	NULL
control	NULL
or	NULL
chronic	NULL
bronchitis	NULL
subjects	NULL
.	NULL

Furthermore	NULL
,	NULL
epithelial	NULL
levels	NULL
of	NULL
activated	NULL
Stat1	NULL
correlated	NULL
with	NULL
levels	NULL
of	NULL
expression	NULL
for	NULL
epithelial	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
,	NULL
and	NULL
in	NULL
turn	NULL
,	NULL
ICAM-1	NULL
levels	NULL
correlated	NULL
with	NULL
T-cell	NULL
accumulation	NULL
in	NULL
tissue	NULL
.	NULL

However	NULL
,	NULL
only	NULL
low	NULL
levels	NULL
of	NULL
IFN-y	NULL
or	NULL
IFN-y-producing	NULL
cells	NULL
were	NULL
detected	NULL
in	NULL
airway	NULL
tissue	NULL
in	NULL
all	NULL
subjects	NULL
.	NULL

The	NULL
results	NULL
therefore	NULL
provide	NULL
initial	NULL
evidence	NULL
linking	NULL
abnormal	NULL
behavior	NULL
of	NULL
STAT	NULL
pathways	NULL
for	NULL
cytokine	NULL
signaling	NULL
to	NULL
the	NULL
development	NULL
of	NULL
an	NULL
inflammatory	NULL
disease	NULL
.	NULL

In	NULL
that	NULL
context	NULL
,	NULL
the	NULL
results	NULL
also	NULL
change	NULL
the	NULL
current	NULL
scheme	NULL
for	NULL
asthma	NULL
pathogenesis	NULL
to	NULL
one	NULL
that	NULL
must	NULL
include	NULL
a	NULL
localized	NULL
gain	NULL
in	NULL
transcriptional	NULL
signal	NULL
ordinarily	NULL
used	NULL
for	NULL
a	NULL
T	NULL
helper	NULL
1-type	NULL
cytokine	NULL
(	NULL
IFN-Y	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
allergy-driven	NULL
overproduction	NULL
of	NULL
T	NULL
helper	NULL
2-type	NULL
cytokines	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

103:1353-1361	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Introduction	NULL
Cytokines	NULL
are	NULL
critical	NULL
for	NULL
regulating	NULL
immunity	NULL
and	NULL
inflammation	NULL
,	NULL
so	NULL
it	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
altered	NULL
cytokine	NULL
production	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
causing	NULL
inflammatory	NULL
diseases	NULL
.	NULL

However	NULL
,	NULL
cytokines	NULL
depend	NULL
on	NULL
signal	NULL
transduction	NULL
pathways	NULL
to	NULL
transmit	NULL
their	NULL
specific	NULL
effects	NULL
,	NULL
so	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
even	NULL
normal	NULL
levels	NULL
of	NULL
cytokines	NULL
coupled	NULL
to	NULL
an	NULL
abnormal	NULL
signaling	NULL
pathway	NULL
could	NULL
lead	NULL
to	NULL
an	NULL
aberrant	NULL
response	NULL
and	NULL
consequent	NULL
inflammation	NULL
.	NULL

Although	NULL
many	NULL
cytokines	NULL
depend	NULL
on	NULL
a	NULL
family	NULL
of	NULL
signaling	NULL
molecules	NULL
designated	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
's	NULL
)	NULL
to	NULL
mediate	NULL
specific	NULL
respons-es	NULL
,	NULL
the	NULL
behavior	NULL
of	NULL
STAT	NULL
proteins	NULL
during	NULL
the	NULL
abnormal	NULL
immune	NULL
cell	NULL
responses	NULL
that	NULL
characterize	NULL
inflammatory	NULL
diseases	NULL
remain	NULL
uncertain	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
asthma	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
common	NULL
immune	NULL
disorders	NULL
and	NULL
has	NULL
been	NULL
characterized	NULL
as	NULL
an	NULL
inflammatory	NULL
airway	NULL
disease	NULL
with	NULL
eosinophil	NULL
influx	NULL
and	NULL
a	NULL
predisposition	NULL
to	NULL
allergic	NULL
reactions	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
to	NULL
murine	NULL
immunology	NULL
,	NULL
the	NULL
disease	NULL
has	NULL
been	NULL
further	NULL
categorized	NULL
as	NULL
manifesting	NULL
an	NULL
aberrant	NULL
immune	NULL
response	NULL
biased	NULL
toward	NULL
production	NULL
of	NULL
T-helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cytokines	NULL
such	NULL
as	NULL
IL-4	NULL
and	NULL
IL-5	NULL
and	NULL
away	NULL
from	NULL
T-helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cytokines	NULL
such	NULL
as	NULL
IFN-y	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

Because	NULL
not	NULL
all	NULL
patients	NULL
with	NULL
asthma	NULL
have	NULL
an	NULL
identifiable	NULL
allergic	NULL
trigger	NULL
for	NULL
their	NULL
disease	NULL
,	NULL
we	NULL
have	NULL
questioned	NULL
the	NULL
``	NULL
Th2	NULL
diathesis	NULL
``	NULL
as	NULL
a	NULL
sole	NULL
explanation	NULL
for	NULL
asthma	NULL
and	NULL
have	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
other	NULL
aspects	NULL
of	NULL
airway	NULL
immunity	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

We	NULL
have	NULL
provided	NULL
evidence	NULL
for	NULL
the	NULL
role	NULL
of	NULL
epithelial	NULL
immune-response	NULL
genes	NULL
in	NULL
mucosal	NULL
immunity	NULL
and	NULL
the	NULL
possibility	NULL
that	NULL
abnormal	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
may	NULL
lead	NULL
to	NULL
airway	NULL
inflammation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

This	NULL
alternative	NULL
features	NULL
an	NULL
IFN-y-responsive	NULL
signaling	NULL
pathway	NULL
that	NULL
relies	NULL
on	NULL
the	NULL
dual	NULL
ability	NULL
of	NULL
the	NULL
initial	NULL
member	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
(	NULL
Stat1	NULL
)	NULL
to	NULL
first	NULL
be	NULL
phosphorylated	NULL
and	NULL
dimerized	NULL
by	NULL
the	NULL
IFN-y-receptor	NULL
complex	NULL
and	NULL
then	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
selectively	NULL
transactivate	NULL
genes	NULL
containing	NULL
a	NULL
Stat1	NULL
binding	NULL
site	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

In	NULL
airway	NULL
epithelial	NULL
cells	NULL
,	NULL
this	NULL
Stat1-dependent	NULL
pathway	NULL
is	NULL
thereby	NULL
programmed	NULL
for	NULL
IFN-y-inducible	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
immune-response	NULL
target	NULL
genes	NULL
typified	NULL
by	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Distribution	NULL
of	NULL
ICAM-1	NULL
along	NULL
the	NULL
epithelial	NULL
cell	NULL
surface	NULL
is	NULL
then	NULL
positioned	NULL
to	NULL
mediate	NULL
epithelial	NULL
T-cell	NULL
interac-tion	NULL
,	NULL
including	NULL
cell-cell	NULL
adhesion	NULL
and	NULL
antigen	NULL
presentation	NULL
(	NULL
14	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
whereas	NULL
concomitant	NULL
expression	NULL
of	NULL
other	NULL
subset	NULL
members	NULL
such	NULL
as	NULL
IFN	NULL
regulatory	NULL
factor	NULL
1	NULL
(	NULL
IRF-1	NULL
)	NULL
coordinate	NULL
other	NULL
aspects	NULL
of	NULL
mucosal	NULL
immunity	NULL
relevant	NULL
to	NULL
antiviral	NULL
defense	NULL
(	NULL
18	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
aimed	NULL
to	NULL
extend	NULL
our	NULL
findings	NULL
on	NULL
epithelial	NULL
cell	NULL
behavior	NULL
to	NULL
studies	NULL
of	NULL
human	NULL
subjects	NULL
,	NULL
taking	NULL
advantage	NULL
of	NULL
the	NULL
capacity	NULL
for	NULL
Stat1	NULL
and	NULL
a	NULL
subset	NULL
of	NULL
Stat1-dependent	NULL
genes	NULL
to	NULL
respond	NULL
selectively	NULL
to	NULL
IFN-y	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
(	NULL
15-19	NULL
,	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
bronchial	NULL
epithelial	NULL
Statl	NULL
is	NULL
activated	NULL
in	NULL
concert	NULL
with	NULL
expression	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
in	NULL
stable	NULL
asthma	NULL
,	NULL
but	NULL
not	NULL
in	NULL
normal	NULL
controls	NULL
or	NULL
in	NULL
subjects	NULL
with	NULL
airway	NULL
inflammation	NULL
due	NULL
to	NULL
chronic	NULL
bronchitis	NULL
.	NULL

Because	NULL
tissue	NULL
levels	NULL
of	NULL
IFN-	NULL
y	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|	NULL
Number	NULL
9	NULL
1353	NULL
Table	NULL
1	NULL
Characteristics	NULL
of	NULL
subjects	NULL
Characteristic	NULL
Normal	NULL
control	NULL
_	NULL
Asthma	NULL
-	NULL
Chronic	NULL
bronchitis	NULL
subjects	NULL
subjects	NULL
subjects	NULL
(	NULL
n	NULL
=11	NULL
)	NULL
(	NULL
n	NULL
=	NULL
24	NULL
)	NULL
(	NULL
n=	NULL
8	NULL
)	NULL
Age	NULL
(	NULL
years	NULL
)	NULL
Mean	NULL
32	NULL
36	NULL
67	NULL
Range	NULL
20-54	NULL
20-64	NULL
42-76	NULL
Gender	NULL
(	NULL
male/female	NULL
)	NULL
7/4	NULL
10/14	NULL
3/5	NULL
Atopy	NULL
4	NULL
22	NULL
ND	NULL
Glucocorticoid	NULL
treatment	NULL
0	NULL
2	NULL
2	NULL
FEV14	NULL
(	NULL
L/min	NULL
)	NULL
+	NULL
SD	NULL
4.25	NULL
+	NULL
0.78	NULL
2.64	NULL
+	NULL
1.07	NULL
1.24	NULL
£	NULL
0.74	NULL
Percent	NULL
predicted	NULL
+	NULL
SD	NULL
106	NULL
+	NULL
13	NULL
80	NULL
+	NULL
28	NULL
51	NULL
+10	NULL
Range	NULL
of	NULL
percent	NULL
predicted	NULL
81-129	NULL
27-114	NULL
41-69	NULL
FEV1	NULL
PC20®	NULL
(	NULL
mg/mL	NULL
)	NULL
£	NULL
SD	NULL
>	NULL
16	NULL
1.21	NULL
+	NULL
2.06	NULL
ND	NULL
range	NULL
>	NULL
16	NULL
0.025-7.5	NULL
ND	NULL
ADenotes	NULL
forced	NULL
expiratory	NULL
volume	NULL
in	NULL
1	NULL
second	NULL
.	NULL

®Denotes	NULL
provocative	NULL
concentration	NULL
of	NULL
methacholine	NULL
required	NULL
to	NULL
cause	NULL
a	NULL
20	NULL
%	NULL
decrease	NULL
in	NULL
baseline	NULL
FEV1	NULL
.	NULL

Not	NULL
determined	NULL
.	NULL

are	NULL
not	NULL
increased	NULL
,	NULL
asthma	NULL
appears	NULL
to	NULL
be	NULL
characterized	NULL
by	NULL
constitutive	NULL
activity	NULL
of	NULL
Th1-like	NULL
cytokine	NULL
signaling	NULL
,	NULL
even	NULL
without	NULL
evidence	NULL
of	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
IFN-y	NULL
or	NULL
viral	NULL
infection	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
,	NULL
that	NULL
normally	NULL
drive	NULL
this	NULL
type	NULL
of	NULL
immune	NULL
reaction	NULL
.	NULL

Methods	NULL
Study	NULL
subjects	NULL
.	NULL

Eleven	NULL
healthy	NULL
control	NULL
,	NULL
24	NULL
asthma	NULL
,	NULL
and	NULL
8	NULL
chronic	NULL
bronchitis	NULL
subjects	NULL
were	NULL
recruited	NULL
,	NULL
using	NULL
informed	NULL
consent	NULL
for	NULL
a	NULL
protocol	NULL
approved	NULL
by	NULL
the	NULL
University	NULL
Committee	NULL
for	NULL
Human	NULL
Studies	NULL
,	NULL
and	NULL
were	NULL
characterized	NULL
by	NULL
spirometry	NULL
,	NULL
airway	NULL
reactivity	NULL
to	NULL
inhaled	NULL
methacholine	NULL
,	NULL
and	NULL
skin	NULL
test	NULL
reactivity	NULL
-	NULL
as	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Control	NULL
subjects	NULL
had	NULL
no	NULL
clinical	NULL
history	NULL
of	NULL
airway	NULL
obstruction	NULL
and	NULL
had	NULL
normal	NULL
spirometry	NULL
and	NULL
normal	NULL
airway	NULL
reactivity	NULL
.	NULL

Asthmatic	NULL
subjects	NULL
met	NULL
clinical	NULL
diagnostic	NULL
criteria	NULL
for	NULL
asthma	NULL
(	NULL
26	NULL
)	NULL
and	NULL
showed	NULL
hyperreactivity	NULL
to	NULL
inhaled	NULL
metha-choline	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
asthmatic	NULL
subjects	NULL
were	NULL
being	NULL
treated	NULL
with	NULL
inhaled	NULL
glucocorticoids	NULL
at	NULL
the	NULL
time	NULL
of	NULL
study	NULL
.	NULL

Positive	NULL
skin	NULL
test	NULL
reactivity	NULL
to	NULL
a	NULL
panel	NULL
of	NULL
allergens	NULL
(	NULL
house	NULL
dust	NULL
,	NULL
trees	NULL
,	NULL
grasses	NULL
,	NULL
fungi	NULL
,	NULL
cockroach	NULL
,	NULL
and	NULL
dog	NULL
and	NULL
cat	NULL
dander	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
22	NULL
of	NULL
the	NULL
asthmatic	NULL
subjects	NULL
and	NULL
4	NULL
of	NULL
the	NULL
control	NULL
subjects	NULL
.	NULL

Chronic	NULL
bronchitis	NULL
subjects	NULL
met	NULL
clinical	NULL
diagnostic	NULL
criteria	NULL
for	NULL
chronic	NULL
bronchitis	NULL
(	NULL
26	NULL
)	NULL
and	NULL
had	NULL
airflow	NULL
obstruction	NULL
.	NULL

For	NULL
all	NULL
subjects	NULL
,	NULL
there	NULL
was	NULL
no	NULL
history	NULL
of	NULL
endotracheal	NULL
intubation	NULL
within	NULL
the	NULL
past	NULL
5	NULL
years	NULL
,	NULL
respiratory	NULL
tract	NULL
infection	NULL
within	NULL
the	NULL
past	NULL
3	NULL
months	NULL
,	NULL
or	NULL
significant	NULL
cardiac	NULL
or	NULL
neurologic	NULL
disease	NULL
.	NULL

Procurement	NULL
and	NULL
processing	NULL
of	NULL
cells	NULL
and	NULL
tissue	NULL
.	NULL

Endobronchial	NULL
biopsies	NULL
and	NULL
brushings	NULL
were	NULL
obtained	NULL
from	NULL
all	NULL
subjects	NULL
using	NULL
a	NULL
fiberoptic	NULL
bronchoscope	NULL
.	NULL

For	NULL
each	NULL
subject	NULL
,	NULL
6-8	NULL
endobronchial	NULL
biopsies	NULL
of	NULL
proximal	NULL
airway	NULL
tissue	NULL
were	NULL
obtained	NULL
from	NULL
undisturbed	NULL
areas	NULL
using	NULL
a	NULL
2-mm	NULL
forceps	NULL
,	NULL
and	NULL
endobronchial	NULL
brushings	NULL
were	NULL
obtained	NULL
from	NULL
10	NULL
separate	NULL
airway	NULL
segments	NULL
using	NULL
a	NULL
cytology	NULL
brush	NULL
.	NULL

Endobronchial	NULL
biopsies	NULL
were	NULL
either	NULL
frozen	NULL
in	NULL
Tissue-Tek	NULL
OCT	NULL
(	NULL
Sakura	NULL
Finetek	NULL
,	NULL
Torrance	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
TBS	NULL
Tissue	NULL
Freezing	NULL
Medium	NULL
(	NULL
Triangular	NULL
Biomedical	NULL
Science	NULL
Durham	NULL
,	NULL
North	NULL
Carolina	NULL
,	NULL
USA	NULL
)	NULL
or	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
neutral-buffered	NULL
formalin	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
.	NULL

Endobronchial	NULL
brushings	NULL
were	NULL
collected	NULL
in	NULL
ice-cold	NULL
serum-free	NULL
RPMI-1640	NULL
media	NULL
containing	NULL
amphotericin	NULL
B	NULL
,	NULL
penicillin/streptomycin	NULL
,	NULL
and	NULL
L-glutamine	NULL
;	NULL
they	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
and	NULL
subjected	NULL
to	NULL
hypotonic	NULL
lysis	NULL
to	NULL
eliminate	NULL
red	NULL
blood	NULL
cells	NULL
.	NULL

Brushings	NULL
obtained	NULL
in	NULL
this	NULL
manner	NULL
contained	NULL
cells	NULL
that	NULL
were	NULL
50-80	NULL
%	NULL
viable	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Airway	NULL
epithelial	NULL
cells	NULL
from	NULL
all	NULL
subjects	NULL
comprised	NULL
>	NULL
95	NULL
%	NULL
of	NULL
brushed	NULL
cells	NULL
,	NULL
based	NULL
on	NULL
morphology	NULL
and	NULL
immunostaining	NULL
with	NULL
anti-cytokeratin	NULL
mAb	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
cytocentrifugation	NULL
onto	NULL
glass	NULL
slides	NULL
fol-	NULL
lowed	NULL
by	NULL
fixation	NULL
with	NULL
acetone/methanol	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
25°C	NULL
,	NULL
and	NULL
slides	NULL
were	NULL
air	NULL
dried	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
for	NULL
subsequent	NULL
immunostaining	NULL
.	NULL

The	NULL
remaining	NULL
portion	NULL
of	NULL
brushed	NULL
cells	NULL
was	NULL
lysed	NULL
in	NULL
100	NULL
uL	NULL
of	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
NP-40	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
stored	NULL
at	NULL
-20°C	NULL
for	NULL
immunoblotting	NULL
.	NULL

In	NULL
some	NULL
subjects	NULL
,	NULL
bronchoalveolar	NULL
lavage	NULL
(	NULL
with	NULL
five	NULL
20-mL	NULL
aliquots	NULL
of	NULL
0.9	NULL
%	NULL
NaCI	NULL
)	NULL
was	NULL
also	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
fluid	NULL
was	NULL
used	NULL
to	NULL
isolate	NULL
macrophages	NULL
(	NULL
>	NULL
95	NULL
%	NULL
purity	NULL
and	NULL
via-bility	NULL
)	NULL
by	NULL
differential	NULL
adherence	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Lysates	NULL
of	NULL
bronchoalveolar	NULL
macrophages	NULL
and	NULL
primary-culture	NULL
human	NULL
tracheobronchial	NULL
epithelial	NULL
cells	NULL
(	NULL
14-20	NULL
,	NULL
22	NULL
)	NULL
were	NULL
also	NULL
immunoblotted	NULL
for	NULL
comparison	NULL
to	NULL
brushed	NULL
epithelial	NULL
cells	NULL
.	NULL

Immunomicroscopy	NULL
.	NULL

Cytospin	NULL
preparations	NULL
of	NULL
epithelial	NULL
cell	NULL
brushings	NULL
were	NULL
treated	NULL
with	NULL
2	NULL
%	NULL
gelatin	NULL
to	NULL
block	NULL
nonspecific	NULL
Ig	NULL
binding	NULL
and	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
anti-Stat1	NULL
mAb	NULL
(	NULL
12	NULL
ug/ml	NULL
;	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
Kentucky	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
anti-cytokeratin	NULL
mAb	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
or	NULL
nonimmune	NULL
isotype-matched	NULL
mouse	NULL
IgG	NULL
for	NULL
18	NULL
hours	NULL
at	NULL
4°C	NULL
.	NULL

Primary	NULL
Ab	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
TRITC-conjugated	NULL
donkey	NULL
anti-mouse	NULL
IgG	NULL
Ab	NULL
(	NULL
5	NULL
ug/mL	NULL
;	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
,	NULL
Bar	NULL
Harbor	NULL
,	NULL
Maine	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Stat1	NULL
nuclear	NULL
translocation	NULL
was	NULL
detected	NULL
by	NULL
colocalization	NULL
with	NULL
bisbenzimide	NULL
(	NULL
norcHst	NULL
)	NULL
and	NULL
was	NULL
quantified	NULL
by	NULL
assessing	NULL
250	NULL
cytokeratin-immunopositive	NULL
cells	NULL
for	NULL
each	NULL
subject	NULL
.	NULL

Frozen	NULL
endobronchial	NULL
biopsies	NULL
were	NULL
cut	NULL
into	NULL
sections	NULL
that	NULL
were	NULL
washed	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
blocked	NULL
by	NULL
treatment	NULL
with	NULL
2	NULL
%	NULL
gelatin	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
anti-Stat1l	NULL
mAb	NULL
(	NULL
12	NULL
g/mL	NULL
)	NULL
,	NULL
anti-ICAM-1	NULL
mAb	NULL
84H10	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
Immunotech	NULL
,	NULL
Westbrook	NULL
,	NULL
Maine	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
anti-p65	NULL
(	NULL
RelA	NULL
)	NULL
subunit	NULL
of	NULL
nuclear	NULL
factor-kB	NULL
(	NULL
NF-KB	NULL
)	NULL
pAb	NULL
(	NULL
2	NULL
g/mL	NULL
)	NULL
,	NULL
or	NULL
anti-c-fos	NULL
subunit	NULL
of	NULL
activator	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
pAb	NULL
(	NULL
2	NULL
g/mL	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
for	NULL
18	NULL
hours	NULL
at	NULL
4°C	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
Stat1	NULL
,	NULL
NF-KB	NULL
,	NULL
or	NULL
AP-1	NULL
activation	NULL
,	NULL
some	NULL
biopsy	NULL
samples	NULL
were	NULL
also	NULL
stimulated	NULL
for	NULL
24	NULL
hours	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
,	NULL
TNF-	NULL
@	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
,	NULL
respec-tively	NULL
.	NULL

Primary	NULL
Ab	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
FITC-	NULL
or	NULL
TRITC-conjugated	NULL
donkey	NULL
anti-mouse	NULL
IgG	NULL
Ab	NULL
and	NULL
then	NULL
viewed	NULL
by	NULL
scanning	NULL
laser	NULL
confocal	NULL
microscopy	NULL
with	NULL
images	NULL
generated	NULL
at	NULL
x600	NULL
using	NULL
a	NULL
computer	NULL
interface	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Stat1	NULL
translocation	NULL
was	NULL
quantified	NULL
by	NULL
analyzing	NULL
a	NULL
field	NULL
of	NULL
epithelium	NULL
in	NULL
each	NULL
biopsy	NULL
section	NULL
.	NULL

Formalin-fixed	NULL
biopsies	NULL
were	NULL
also	NULL
cut	NULL
into	NULL
6-/im	NULL
sections	NULL
.	NULL

Tissue	NULL
sections	NULL
were	NULL
deparaffinized	NULL
and	NULL
rehydrated	NULL
with	NULL
graded	NULL
ethanol	NULL
solutions	NULL
,	NULL
and	NULL
endogenous	NULL
peroxidase	NULL
activity	NULL
was	NULL
blocked	NULL
by	NULL
treatment	NULL
with	NULL
3	NULL
%	NULL
hydrogen	NULL
peroxide	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
25°C	NULL
.	NULL

Antigen	NULL
exposure	NULL
was	NULL
facilitated	NULL
by	NULL
an	NULL
antigen-retrieval	NULL
method	NULL
in	NULL
which	NULL
tissue	NULL
specimens	NULL
were	NULL
placed	NULL
in	NULL
10	NULL
mM	NULL
Citra	NULL
solution	NULL
(	NULL
BioGenex	NULL
Laboratories	NULL
,	NULL
San	NULL
Ramon	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
98°C	NULL
.	NULL

After	NULL
tissue	NULL
specimens	NULL
cooled	NULL
to	NULL
25°C	NULL
,	NULL
nonspecific	NULL
antigens	NULL
were	NULL
blocked	NULL
by	NULL
exposure	NULL
to	NULL
3	NULL
%	NULL
nonimmune	NULL
horse	NULL
serum	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
25°C	NULL
.	NULL

Slides	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
anti-Stat1	NULL
and	NULL
anti-ICAM-1	NULL
mAb	NULL
as	NULL
already	NULL
described	NULL
here	NULL
,	NULL
and	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
1	NULL
ug/mL	NULL
)	NULL
from	NULL
BioGenex	NULL
.	NULL

Primary	NULL
Ab	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
biotinylated	NULL
horse	NULL
anti-mouse	NULL
IgG	NULL
Ab	NULL
,	NULL
streptavidin-conjugated	NULL
alkaline	NULL
phosphatase	NULL
,	NULL
and	NULL
red	NULL
chro-mogenic	NULL
substrate	NULL
(	NULL
Vector	NULL
Laboratories	NULL
,	NULL
Burlingame	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Tissue	NULL
sections	NULL
were	NULL
counterstained	NULL
with	NULL
hema-toxylin	NULL
,	NULL
dehydrated	NULL
in	NULL
graded	NULL
ethanol	NULL
,	NULL
and	NULL
mounted	NULL
for	NULL
viewing	NULL
and	NULL
photomicrography	NULL
.	NULL

To	NULL
quantitate	NULL
immunos-taining	NULL
,	NULL
images	NULL
were	NULL
acquired	NULL
using	NULL
the	NULL
Pax	NULL
It	NULL
computer	NULL
program	NULL
(	NULL
Midwest	NULL
Information	NULL
Systems	NULL
,	NULL
Franklin	NULL
Park	NULL
,	NULL
Illinois	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
an	NULL
image	NULL
analysis	NULL
program	NULL
(	NULL
Opti-mus	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
,	NULL
USA	NULL
)	NULL
set	NULL
to	NULL
calculate	NULL
red	NULL
intensity	NULL
of	NULL
a	NULL
square	NULL
of	NULL
airway	NULL
epithelium	NULL
(	NULL
50	NULL
x	NULL
50	NULL
mm	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
same-sized	NULL
square	NULL
of	NULL
subepithelium	NULL
using	NULL
an	NULL
RGB	NULL
scale	NULL
.	NULL

Red	NULL
intensity	NULL
was	NULL
calculated	NULL
for	NULL
5	NULL
squares	NULL
of	NULL
epithelium	NULL
and	NULL
averaged	NULL
to	NULL
obtain	NULL
a	NULL
value	NULL
for	NULL
each	NULL
biopsy	NULL
.	NULL

1354	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number9	NULL
1007	NULL
P	NULL
<	NULL
0.0001	NULL
P	NULL
<	NULL
0.0001	NULL
Se	NULL
CBD	NULL
f	NULL
s	NULL
Stat1	NULL
Activation	NULL
(	NULL
%	NULL
cslls	NULL
with	NULL
nuclear	NULL
Stat1	NULL
)	NULL
o	NULL
1	NULL
[	NULL
el	NULL
O	NULL
IJ	NULL
38	NULL
o	NULL
co	NULL
Normal	NULL
Asthma	NULL
Chronic	NULL
Control	NULL
Bronchitis	NULL
Figure	NULL
1	NULL
Stat	NULL
]	NULL
activation	NULL
in	NULL
asthma	NULL
detected	NULL
by	NULL
nuclear	NULL
translocation	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
.	NULL

(	NULL
a-f	NULL
)	NULL
Representative	NULL
immunofluorescence	NULL
photomicrographs	NULL
of	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
brushed	NULL
from	NULL
control	NULL
(	NULL
a	NULL
and	NULL
d	NULL
)	NULL
,	NULL
asthma	NULL
(	NULL
b	NULL
and	NULL
e	NULL
)	NULL
,	NULL
and	NULL
chronic	NULL
bronchitis	NULL
(	NULL
e	NULL
and	NULL
£	NULL
)	NULL
subjects	NULL
;	NULL
immunostained	NULL
with	NULL
anti-Stat1	NULL
Ab	NULL
plus	NULL
TRITC-conjugated	NULL
secondary	NULL
Ab	NULL
;	NULL
and	NULL
then	NULL
counterstained	NULL
with	NULL
bisbenzimide	NULL
to	NULL
localize	NULL
cell	NULL
nuclei	NULL
(	NULL
indicated	NULL
by	NULL
arrowheads	NULL
)	NULL
.	NULL

(	NULL
a-c	NULL
)	NULL
Stat	NULL
!	NULL

plus	NULL
bisbenzimide	NULL
signals	NULL
(	NULL
red	NULL
plus	NULL
blue	NULL
fluorescence	NULL
)	NULL
.	NULL

(	NULL
d-f	NULL
)	NULL
Stat1	NULL
signal	NULL
(	NULL
red	NULL
fluorescence	NULL
)	NULL
.	NULL

Control	NULL
staining	NULL
with	NULL
nonimmune	NULL
IgG	NULL
gave	NULL
no	NULL
detectable	NULL
signal	NULL
above	NULL
background	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
g	NULL
)	NULL
Quantitative	NULL
analysis	NULL
of	NULL
Stat1	NULL
nuclear	NULL
translocation	NULL
for	NULL
all	NULL
subjects	NULL
.	NULL

Values	NULL
were	NULL
derived	NULL
by	NULL
calculating	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
which	NULL
Stat1	NULL
colocalized	NULL
with	NULL
bisbenzimide	NULL
out	NULL
of	NULL
250	NULL
cytokeratin-staining	NULL
cells	NULL
per	NULL
subject	NULL
.	NULL

Scale	NULL
bar	NULL
:	NULL
15	NULL
LM	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
for	NULL
Stat1	NULL
phosphorylation	NULL
and	NULL
for	NULL
Stat1	NULL
and	NULL
IRF-1	NULL
expression	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
in	NULL
0.1	NULL
%	NULL
NP-40	NULL
,	NULL
1.0	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
buffers	NULL
containing	NULL
pro-tease	NULL
inhibitors	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
(	NULL
100	NULL
ug/condition	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
agarose-conjugated	NULL
anti-Stat1	NULL
pAb	NULL
(	NULL
20	NULL
l	NULL
)	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc	NULL
.	NULL

The	NULL
immune	NULL
complex	NULL
was	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
using	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membranes	NULL
that	NULL
were	NULL
probed	NULL
with	NULL
1	NULL
juug/mL	NULL
of	NULL
anti-phosphotyrosine	NULL
mAb	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
PY20-H	NULL
)	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
.	NULL

Binding	NULL
was	NULL
detected	NULL
by	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
method	NULL
(	NULL
Amersham	NULL
Interna-tional	NULL
,	NULL
Amersham	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

PVDF	NULL
membranes	NULL
were	NULL
reprobed	NULL
with	NULL
anti-Stat1	NULL
mAb	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
to	NULL
confirm	NULL
the	NULL
identity	NULL
of	NULL
phosphorylated	NULL
Stat1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
levels	NULL
of	NULL
Stat1	NULL
and	NULL
IRF-1	NULL
were	NULL
determined	NULL
by	NULL
immunoblotting	NULL
lysates	NULL
(	NULL
without	NULL
prior	NULL
immunoprecipitation	NULL
)	NULL
using	NULL
anti-Stat1	NULL
mAb	NULL
(	NULL
1	NULL
ug/mL	NULL
)	NULL
,	NULL
anti-IRF-1	NULL
pAb	NULL
(	NULL
1	NULL
ug/mL	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
,	NULL
and	NULL
(	NULL
as	NULL
a	NULL
control	NULL
)	NULL
anti-B-actin	NULL
mAb	NULL
(	NULL
0.5	NULL
g/mL	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
bybridization	NULL
.	NULL

For	NULL
IFN-y	NULL
riboprobe	NULL
synthesis	NULL
,	NULL
a	NULL
0.9-kb	NULL
human	NULL
cDNA	NULL
fragment	NULL
(	NULL
nt	NULL
1-900	NULL
)	NULL
was	NULL
positionally	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pGEM3Zf-1	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
Wisconsin	NULL
,	NULL
USA	NULL
)	NULL
to	NULL
generate	NULL
pGEM3Zf-1-IFN-y	NULL
(	NULL
1-900	NULL
)	NULL
.	NULL

Radiolabeled	NULL
*5S-UTP	NULL
sense	NULL
and	NULL
antisense	NULL
cRNA	NULL
transcripts	NULL
were	NULL
transcribed	NULL
in	NULL
vitro	NULL
by	NULL
T3	NULL
and	NULL
T7	NULL
RNA	NULL
poly-merases	NULL
,	NULL
respectively	NULL
,	NULL
using	NULL
the	NULL
Gemini	NULL
Riboprobe	NULL
system	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
,	NULL
using	NULL
biopsy	NULL
tissue	NULL
that	NULL
was	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
500	NULL
ng/mL	NULL
)	NULL
for	NULL
5	NULL
hours	NULL
at	NULL
37°C	NULL
.	NULL

RT-PCR	NULL
.	NULL

Airway	NULL
tissue	NULL
levels	NULL
of	NULL
IFN-y	NULL
mRNA	NULL
were	NULL
quantified	NULL
using	NULL
RT-PCR	NULL
with	NULL
primers	NULL
specific	NULL
for	NULL
IFN-y	NULL
,	NULL
IL-4	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
,	NULL
and	NULL
B-actin	NULL
(	NULL
internal	NULL
standard	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
from	NULL
tissue	NULL
homogenates	NULL
of	NULL
3-4	NULL
endobronchial	NULL
biopsies	NULL
per	NULL
subject	NULL
and	NULL
from	NULL
PMA/ionomycin-stimulated	NULL
PBMCs	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
RNA	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
with	NULL
the	NULL
Ready-To-Go	NULL
kit	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
,	NULL
and	NULL
cDNA	NULL
was	NULL
amplified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200	NULL
nM	NULL
S5'-sense	NULL
and	NULL
3'-antisense	NULL
primers	NULL
for	NULL
IFN-y	NULL
-	NULL
(	NULL
ATGAAATATACAAGTTATATCTTGG-CTTT	NULL
and	NULL
GATGCTCTTCGACCTCGAAGCAT	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
ATGGGTCTCAC-CTCCCAACTGCT	NULL
and	NULL
CGAACACTTTGAATATTTCTCTCT-CAT	NULL
)	NULL
,	NULL
or	NULL
B-actin	NULL
(	NULL
TGACGGGGTCACCCACACTGTGCCCAT-CTA	NULL
and	NULL
CTAGAAGCATTGCGGTGGACGATGGA-GGG	NULL
)	NULL
,	NULL
200	NULL
uM	NULL
dNTPs	NULL
,	NULL
and	NULL
0.5	NULL
U	NULL
polymerase	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Maryland	NULL
,	NULL
USA	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
with	NULL
2.5	NULL
LM	NULL
MgCl	NULL
;	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
0.001	NULL
%	NULL
gelatin	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
for	NULL
40	NULL
cycles	NULL
with	NULL
a	NULL
45-second	NULL
denaturation	NULL
at	NULL
95°C	NULL
,	NULL
45-second	NULL
annealing	NULL
at	NULL
55°C	NULL
,	NULL
and	NULL
45-second	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
IFN-y	NULL
and	NULL
B-actin	NULL
;	NULL
and	NULL
for	NULL
40	NULL
cycles	NULL
with	NULL
45-second	NULL
denaturation	NULL
at	NULL
95°C	NULL
,	NULL
45-second	NULL
annealing	NULL
at	NULL
60°C	NULL
,	NULL
and	NULL
1.5-minute	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
IL-4	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
were	NULL
detected	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
in	NULL
ethidium	NULL
bromide	NULL
and	NULL
migrated	NULL
at	NULL
appropriate	NULL
sizes	NULL
for	NULL
IFN-y	NULL
(	NULL
501	NULL
bp	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
456	NULL
bp	NULL
)	NULL
,	NULL
and	NULL
B-actin	NULL
(	NULL
605	NULL
bp	NULL
)	NULL
.	NULL

Amplified	NULL
IFN-y	NULL
cDNA	NULL
products	NULL
that	NULL
were	NULL
undetectable	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
were	NULL
transferred	NULL
(	NULL
along	NULL
with	NULL
B-actin	NULL
)	NULL
to	NULL
nylon	NULL
membranes	NULL
by	NULL
capillary	NULL
electrophoresis	NULL
,	NULL
and	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
cDNAs	NULL
for	NULL
IFN-y	NULL
(	NULL
GACCATCAAGGAAGACATGAATGTCAAGTT	NULL
)	NULL
or	NULL
B-actin	NULL
(	NULL
GGCTGGCCCCGACCTGACTGACTAC-CTCAT	NULL
)	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

Data	NULL
for	NULL
immunostaining	NULL
and	NULL
in	NULL
situ	NULL
hybridization	NULL
were	NULL
analyzed	NULL
using	NULL
SAS	NULL
statistical	NULL
software	NULL
(	NULL
SAS	NULL
Inc.	NULL
,	NULL
Cary	NULL
,	NULL
North	NULL
Carolina	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

When	NULL
data	NULL
were	NULL
available	NULL
in	NULL
only	NULL
2	NULL
groups	NULL
,	NULL
¢	NULL
tests	NULL
were	NULL
used	NULL
to	NULL
make	NULL
comparisons	NULL
.	NULL

When	NULL
data	NULL
were	NULL
available	NULL
in	NULL
all	NULL
3	NULL
groups	NULL
,	NULL
ANOVA	NULL
was	NULL
used	NULL
to	NULL
perform	NULL
pairwise	NULL
comparisons	NULL
.	NULL

When	NULL
the	NULL
data	NULL
were	NULL
not	NULL
normally	NULL
dis-tributed	NULL
,	NULL
or	NULL
if	NULL
the	NULL
equal	NULL
variance	NULL
assumption	NULL
of	NULL
the	NULL
ANOVA	NULL
was	NULL
violated	NULL
,	NULL
the	NULL
data	NULL
were	NULL
transformed	NULL
before	NULL
performing	NULL
the	NULL
analysis	NULL
.	NULL

The	NULL
square	NULL
root	NULL
transformation	NULL
was	NULL
applied	NULL
to	NULL
Stat1	NULL
activation	NULL
to	NULL
stabilize	NULL
the	NULL
variance	NULL
;	NULL
the	NULL
analysis	NULL
of	NULL
CD3	NULL
was	NULL
applied	NULL
to	NULL
the	NULL
ranks	NULL
of	NULL
the	NULL
original	NULL
data	NULL
;	NULL
and	NULL
percent	NULL
FEV1	NULL
predicted	NULL
and	NULL
ICAM-1	NULL
expression	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
square	NULL
root	NULL
of	NULL
the	NULL
ranks	NULL
of	NULL
the	NULL
data	NULL
.	NULL

A	NULL
P	NULL
value	NULL
of	NULL
less	NULL
than	NULL
0.05	NULL
was	NULL
considered	NULL
to	NULL
indicate	NULL
statistical	NULL
significance	NULL
.	NULL

All	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|	NULL
Number9	NULL
1355	NULL
Figure	NULL
2	NULL
Stat1	NULL
activation	NULL
and	NULL
colocalization	NULL
with	NULL
ICAM-1	NULL
expression	NULL
in	NULL
asthma	NULL
detected	NULL
in	NULL
airway	NULL
epithelial	NULL
tissue	NULL
.	NULL

Representative	NULL
photomicrographs	NULL
from	NULL
scanning	NULL
laser	NULL
confocal	NULL
microscopy	NULL
of	NULL
endobronchial	NULL
biopsy	NULL
sections	NULL
from	NULL
normal	NULL
control	NULL
(	NULL
a	NULL
,	NULL
d	NULL
,	NULL
g	NULL
,	NULL
and	NULL
j	NULL
)	NULL
and	NULL
asthma	NULL
(	NULL
b	NULL
,	NULL
e	NULL
,	NULL
h	NULL
,	NULL
and	NULL
k	NULL
)	NULL
subjects	NULL
,	NULL
and	NULL
from	NULL
normal	NULL
control	NULL
subjects	NULL
after	NULL
biopsy	NULL
stimulation	NULL
ex	NULL
vivo	NULL
with	NULL
IFN-y	NULL
(	NULL
e	NULL
and	NULL
£	NULL
)	NULL
,	NULL
TNF-	NULL
(	NULL
i	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Tissues	NULL
were	NULL
immunostained	NULL
with	NULL
anti-Stat1	NULL
Ab	NULL
(	NULL
a-c	NULL
)	NULL
,	NULL
mAb	NULL
(	NULL
d-f	NULL
)	NULL
,	NULL
anti-p65	NULL
(	NULL
component	NULL
of	NULL
NF-KB	NULL
)	NULL
pAb	NULL
(	NULL
g-i	NULL
)	NULL
,	NULL
or	NULL
anti-c-fos	NULL
(	NULL
component	NULL
of	NULL
AP-1	NULL
)	NULL
pAb	NULL
(	NULL
j-	NULL
)	NULL
.	NULL

Primary	NULL
Ab	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
TRITC-	NULL
or	NULL
FITC-conjugat-ed	NULL
secondary	NULL
Ab	NULL
and	NULL
viewed	NULL
with	NULL
confocal	NULL
microscopy	NULL
scanned	NULL
in	NULL
1-UM	NULL
steps	NULL
along	NULL
the	NULL
z	NULL
axis	NULL
.	NULL

No	NULL
fluorescence	NULL
was	NULL
detected	NULL
for	NULL
monolayers	NULL
stained	NULL
with	NULL
nonimmune	NULL
IgG	NULL
or	NULL
with	NULL
only	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Scale	NULL
bar	NULL
:	NULL
15	NULL
M.	NULL
Results	NULL
1356	NULL
Selective	NULL
activation	NULL
of	NULL
epithelial	NULL
Stat1	NULL
in	NULL
asthma	NULL
.	NULL

Based	NULL
on	NULL
data	NULL
in	NULL
isolated	NULL
airway	NULL
epithelial	NULL
cells	NULL
,	NULL
nuclear	NULL
localization	NULL
appears	NULL
to	NULL
represent	NULL
an	NULL
accurate	NULL
indicator	NULL
of	NULL
Stat1	NULL
activation	NULL
and	NULL
Statl-dependent	NULL
gene	NULL
transcription	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
our	NULL
first	NULL
analysis	NULL
of	NULL
Stat1	NULL
activation	NULL
status	NULL
in	NULL
vivo	NULL
was	NULL
based	NULL
on	NULL
nuclear	NULL
localization	NULL
in	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
brushed	NULL
from	NULL
subjects	NULL
with	NULL
and	NULL
without	NULL
airway	NULL
disease	NULL
.	NULL

Stat1	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
along	NULL
with	NULL
the	NULL
DNA-binding	NULL
dye	NULL
bisbenzimide	NULL
)	NULL
in	NULL
70	NULL
+	NULL
15	NULL
%	NULL
of	NULL
cytoker-atin-immunopositive	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
brushed	NULL
from	NULL
asthmatic	NULL
subjects	NULL
,	NULL
but	NULL
in	NULL
only	NULL
11	NULL
+	NULL
11	NULL
%	NULL
of	NULL
cells	NULL
from	NULL
normal	NULL
controls	NULL
and	NULL
8	NULL
+	NULL
8	NULL
%	NULL
from	NULL
chronic	NULL
bronchitis	NULL
subjects	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Activation	NULL
levels	NULL
of	NULL
epithelial	NULL
Stat1	NULL
were	NULL
increased	NULL
in	NULL
asthmatic	NULL
subjects	NULL
irrespective	NULL
of	NULL
atopy	NULL
or	NULL
glucocorticoid	NULL
treatment	NULL
,	NULL
although	NULL
a	NULL
larger	NULL
sample	NULL
size	NULL
is	NULL
required	NULL
to	NULL
conclude	NULL
that	NULL
Stat1	NULL
activation	NULL
is	NULL
not	NULL
related	NULL
to	NULL
these	NULL
variables	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
control	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
in	NULL
any	NULL
of	NULL
these	NULL
subjects	NULL
of	NULL
activation	NULL
of	NULL
epithelial	NULL
Stat3	NULL
,	NULL
a	NULL
related	NULL
STAT	NULL
protein	NULL
that	NULL
is	NULL
responsive	NULL
to	NULL
IL-6	NULL
and	NULL
IL-6-related	NULL
cytokines	NULL
(	NULL
28	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Evidence	NULL
of	NULL
Stat1	NULL
activation	NULL
,	NULL
based	NULL
on	NULL
nuclear	NULL
translocation	NULL
in	NULL
endobronchial	NULL
brushings	NULL
,	NULL
was	NULL
corroborated	NULL
in	NULL
situ	NULL
using	NULL
endobronchial	NULL
biopsies	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
immuno-fluorescent	NULL
confocal	NULL
microscopy	NULL
indicated	NULL
that	NULL
Stat1	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
4	NULL
+	NULL
1	NULL
%	NULL
of	NULL
cells	NULL
in	NULL
biopsies	NULL
from	NULL
5	NULL
control	NULL
subjects	NULL
but	NULL
was	NULL
detected	NULL
in	NULL
78	NULL
+	NULL
9	NULL
%	NULL
of	NULL
cells	NULL
from	NULL
5	NULL
asthmatic	NULL
subjects	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
cytosolic	NULL
versus	NULL
nuclear	NULL
patterns	NULL
for	NULL
Stat1	NULL
correlated	NULL
precisely	NULL
with	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
ICAM-1	NULL
expression	NULL
on	NULL
a	NULL
cell-by-cell	NULL
basis	NULL
within	NULL
a	NULL
biopsy	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
a-f	NULL
)	NULL
.	NULL

Selective	NULL
activation	NULL
of	NULL
Stat1	NULL
was	NULL
further	NULL
demonstrated	NULL
when	NULL
we	NULL
found	NULL
that	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
)	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
immunity	NULL
and	NULL
inflamma-	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number9	NULL
tion	NULL
,	NULL
as	NULL
well	NULL
as	NULL
asthma	NULL
exacerbations	NULL
and	NULL
subgroups	NULL
(	NULL
29-31	NULL
)	NULL
,	NULL
were	NULL
not	NULL
consistently	NULL
activated	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
of	NULL
these	NULL
stable	NULL
asthmatic	NULL
subjects	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
subjects	NULL
with	NULL
activation	NULL
of	NULL
epithelial	NULL
Stat1	NULL
,	NULL
but	NULL
not	NULL
NF-xB	NULL
or	NULL
AP-1	NULL
,	NULL
still	NULL
exhibit	NULL
ICAM-1	NULL
expression	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
g-1	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
findings	NULL
(	NULL
together	NULL
with	NULL
data	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
and	NULL
Stat1-deficient	NULL
cell	NULL
lines	NULL
showing	NULL
that	NULL
Stat1	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
ICAM-1	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
)	NULL
(	NULL
15-18	NULL
)	NULL
indicates	NULL
that	NULL
Stat	NULL
1	NULL
activation	NULL
is	NULL
likely	NULL
linked	NULL
to	NULL
Stat1-dependent	NULL
expression	NULL
of	NULL
its	NULL
target	NULL
gene	NULL
(	NULL
ICAM-1	NULL
)	NULL
in	NULL
these	NULL
subjects	NULL
.	NULL

Evidence	NULL
of	NULL
Stat1	NULL
activation	NULL
,	NULL
based	NULL
on	NULL
nuclear	NULL
localization	NULL
in	NULL
epithelial	NULL
cells	NULL
from	NULL
bronchial	NULL
brushings	NULL
and	NULL
biopsies	NULL
,	NULL
was	NULL
complemented	NULL
by	NULL
assessment	NULL
of	NULL
Statl	NULL
phosphorylation	NULL
status	NULL
.	NULL

For	NULL
these	NULL
experiments	NULL
,	NULL
Statl1	NULL
immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
indicated	NULL
that	NULL
Stat1	NULL
phosphorylation	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
brushed	NULL
from	NULL
asthmatic	NULL
subjects	NULL
(	NULL
Figure	NULL
3	NULL
,	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
phosphorylated	NULL
to	NULL
unphospho-rylated	NULL
Statl	NULL
was	NULL
increased	NULL
20-fold	NULL
in	NULL
extracts	NULL
of	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
from	NULL
asthmatic	NULL
subjects	NULL
when	NULL
compared	NULL
with	NULL
normal	NULL
control	NULL
or	NULL
chronic	NULL
bronchitis	NULL
subjects	NULL
(	NULL
Figure	NULL
3¢	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Stat1	NULL
activation	NULL
was	NULL
selective	NULL
for	NULL
airway	NULL
epithelial	NULL
cells	NULL
,	NULL
as	NULL
bronchoalveolar	NULL
macrophages	NULL
from	NULL
the	NULL
same	NULL
subjects	NULL
showed	NULL
no	NULL
evidence	NULL
of	NULL
Stat1	NULL
activation	NULL
or	NULL
overexpression	NULL
(	NULL
Figure	NULL
3	NULL
,	NULL
d	NULL
and	NULL
e	NULL
)	NULL
.	NULL

This	NULL
analysis	NULL
provided	NULL
initial	NULL
evidence	NULL
that	NULL
Stat1	NULL
activation	NULL
appeared	NULL
to	NULL
be	NULL
accompanied	NULL
by	NULL
increased	NULL
Stat1	NULL
expression	NULL
(	NULL
based	NULL
on	NULL
the	NULL
intensity	NULL
of	NULL
Stat1	NULL
immunoblotting	NULL
)	NULL
,	NULL
and	NULL
,	NULL
as	NULL
noted	NULL
below	NULL
,	NULL
this	NULL
finding	NULL
was	NULL
confirmed	NULL
with	NULL
additional	NULL
immunoblotting	NULL
and	NULL
immunostaining	NULL
for	NULL
epithelial	NULL
Stat1	NULL
.	NULL

Expression	NULL
of	NULL
Stat1	NULL
-dependent	NULL
genes	NULL
in	NULL
asthma	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
Stat1	NULL
activation	NULL
in	NULL
asthma	NULL
,	NULL
we	NULL
next	NULL
assessed	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
in	NULL
airway	NULL
epithelium	NULL
.	NULL

Induction	NULL
of	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
expression	NULL
depends	NULL
on	NULL
Stat1	NULL
activation	NULL
in	NULL
isolated	NULL
airway	NULL
epithelial	NULL
cells	NULL
(	NULL
15-18	NULL
,	NULL
23	NULL
)	NULL
and	NULL
in	NULL
endobronchial	NULL
biopsies	NULL
stimulated	NULL
ex	NULL
vivo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
so	NULL
we	NULL
reasoned	NULL
that	NULL
Stat1	NULL
activation	NULL
should	NULL
drive	NULL
increased	NULL
expression	NULL
of	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
immunoblotting	NULL
indicated	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
IRF-1	NULL
and	NULL
Stat1	NULL
levels	NULL
in	NULL
brushed	NULL
airway	NULL
epithelial	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
,	NULL
-h	NULL
)	NULL
,	NULL
and	NULL
immunostaining	NULL
indicated	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
expression	NULL
of	NULL
epithelial	NULL
ICAM-1	NULL
and	NULL
Stat1	NULL
in	NULL
asthmatic	NULL
subjects	NULL
compared	NULL
with	NULL
normal	NULL
control	NULL
or	NULL
chronic	NULL
bronchitis	NULL
subjects	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Stat1	NULL
activation	NULL
correlated	NULL
closely	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
ICAM-1	NULL
and	NULL
Stat1	NULL
expression	NULL
for	NULL
all	NULL
3	NULL
groups	NULL
of	NULL
subjects	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
within	NULL
the	NULL
group	NULL
of	NULL
asthmatic	NULL
subjects	NULL
(	NULL
for	NULL
ICAM-1	NULL
:	NULL
r=	NULL
0.51	NULL
and	NULL
P	NULL
=	NULL
0.01	NULL
;	NULL
for	NULL
Stat1	NULL
:	NULL
r=	NULL
0.42	NULL
and	NULL
P	NULL
=	NULL
0.04	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
ICAM-1	NULL
expression	NULL
correlated	NULL
significantly	NULL
with	NULL
the	NULL
numbers	NULL
of	NULL
T	NULL
cells	NULL
found	NULL
in	NULL
endobronchial	NULL
biopsies	NULL
by	NULL
CD3	NULL
immunostaining	NULL
(	NULL
for	NULL
all	NULL
subjects	NULL
,	NULL
r	NULL
=	NULL
0.57	NULL
and	NULL
P	NULL
=	NULL
0.004	NULL
;	NULL
for	NULL
individual	NULL
examples	NULL
,	NULL
see	NULL
Figure	NULL
5	NULL
,	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
data	NULL
for	NULL
the	NULL
behavior	NULL
of	NULL
human	NULL
airway	NULL
epithelial	NULL
cells	NULL
,	NULL
the	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
epithelial	NULL
Stat1	NULL
in	NULL
asthma	NULL
was	NULL
linked	NULL
to	NULL
consequent	NULL
induction	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
(	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
itself	NULL
)	NULL
and	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
ICAM-1	NULL
,	NULL
with	NULL
consequent	NULL
airway	NULL
retention	NULL
of	NULL
immune	NULL
cells	NULL
bearing	NULL
ICAM-1	NULL
counter-receptors	NULL
(	NULL
14	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

CB	NULL
CC	NULL
L	NULL
U	NULL
W	NULL
1	NULL
1	NULL
<	NULL
-	NULL
NB	NULL
#	NULL
==	NULL
<	NULL
-Stati-P	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Lane	NULL
Number	NULL
a	NULL
U	NULL
3	NULL
i	NULL
¢	NULL
4	NULL
8	NULL
A	NULL
€	NULL
a	NULL
*	NULL
Ratio	NULL
of	NULL
Stat1-P/Stat1	NULL
band	NULL
intensity	NULL
(	NULL
%	NULL
)	NULL
7	NULL
o	NULL
L	NULL
Asthma	NULL
T	NULL
1	NULL
1	NULL
M	NULL
E	NULL
M	NULL
-ﬂ—-	NULL
“	NULL
—-	NULL
<	NULL
~sm1	NULL
10	NULL
@	NULL
@	NULL
:	NULL
40	NULL
§00	NULL
600	NULL
r	NULL
os	NULL
NC	NULL
Asthma	NULL
CB	NULL
CC	NULL
I	NULL
1T	NULL
I	NULL
IT	NULL
1	NULL
cts	NULL
«	NULL
m	NULL
wis	NULL
#	NULL
#	NULL
®	NULL
<	NULL
-IRF-1	NULL
«	NULL
<	NULL
»	NULL
ap	NULL
ae	NULL
ear	NULL
Tio	NULL
1	NULL
2	NULL
3	NULL
40	NULL
5	NULL
ene	NULL
«	NULL
-	NULL
Stat1-P	NULL
€-Statin	NULL
.	NULL

<	NULL
€-Statip	NULL
S	NULL
-	NULL
[	NULL
iractin	NULL
Figure	NULL
3	NULL
Stat1	NULL
activation	NULL
in	NULL
asthma	NULL
detected	NULL
by	NULL
protein	NULL
phosphorylation	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Immunoprecipitation/immunoblot	NULL
results	NULL
for	NULL
phosphorylated	NULL
Stat1	NULL
from	NULL
3	NULL
control	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
3	NULL
asthmatic	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
,	NULL
and	NULL
2	NULL
chronic	NULL
bronchitis	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
subjects	NULL
,	NULL
as	NULL
well	NULL
as	NULL
primary-culture	NULL
airway	NULL
epithelial	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
U/mL	NULL
for	NULL
24	NULL
hours	NULL
;	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
Statl	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
epithelial	NULL
cell	NULL
lysates	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-phosphotyrosine	NULL
mAb	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
followed	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

Arrows	NULL
indicate	NULL
positions	NULL
of	NULL
a	NULL
nonspecific	NULL
band	NULL
(	NULL
NB	NULL
)	NULL
and	NULL
phosphorylated	NULL
Stat1	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Results	NULL
for	NULL
total	NULL
Stat	NULL
!	NULL

after	NULL
membranes	NULL
were	NULL
reprobed	NULL
with	NULL
anti-Stat1	NULL
mAb	NULL
.	NULL

Arrows	NULL
indicate	NULL
position	NULL
of	NULL
Stat1	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Ratio	NULL
of	NULL
phosphorylated	NULL
Stat1	NULL
to	NULL
total	NULL
Stat1	NULL
band	NULL
intensity	NULL
for	NULL
each	NULL
condition	NULL
,	NULL
based	NULL
on	NULL
densitometry	NULL
of	NULL
immunoblots	NULL
in	NULL
a	NULL
and	NULL
b	NULL
.	NULL

Using	NULL
the	NULL
same	NULL
techniques	NULL
,	NULL
d	NULL
and	NULL
e	NULL
show	NULL
comparison	NULL
of	NULL
airway	NULL
epithelial	NULL
(	NULL
E	NULL
)	NULL
and	NULL
bronchoalveolar	NULL
macrophage	NULL
(	NULL
M	NULL
)	NULL
levels	NULL
of	NULL
Stat1	NULL
activation	NULL
in	NULL
2	NULL
control	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
and	NULL
2	NULL
asthmatic	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
subjects	NULL
.	NULL

Titration	NULL
of	NULL
sample	NULL
amounts	NULL
to	NULL
provide	NULL
equal	NULL
levels	NULL
of	NULL
Stat1	NULL
in	NULL
each	NULL
lane	NULL
still	NULL
showed	NULL
no	NULL
evidence	NULL
of	NULL
phosphorylation	NULL
in	NULL
samples	NULL
from	NULL
nonasthmatic	NULL
subjects	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
f	NULL
and	NULL
g	NULL
)	NULL
Immunoblots	NULL
(	NULL
without	NULL
prior	NULL
immunoprecipitation	NULL
)	NULL
of	NULL
airway	NULL
epithelial	NULL
cell	NULL
lysates	NULL
for	NULL
IRF-1	NULL
(	NULL
f	NULL
)	NULL
,	NULL
Stat1	NULL
(	NULL
g	NULL
)	NULL
under	NULL
conditions	NULL
that	NULL
separate	NULL
Stat1	NULL
Q	NULL
from	NULL
Stat1B	NULL
,	NULL
and	NULL
control	NULL
B-actin	NULL
(	NULL
h	NULL
)	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number9	NULL
1357	NULL
©	NULL
100	NULL
'	NULL
o	NULL
@	NULL
€	NULL
ONormal	NULL
e	NULL
_	NULL
®	NULL
=	NULL
Control	NULL
%	NULL
n	NULL
@	NULL
Asthma	NULL
®	NULL
€	NULL
@	NULL
Chronic	NULL
a	NULL
Bronchitis	NULL
nfe	NULL
,	NULL
®	NULL
s	NULL
o	NULL
50	NULL
a*	NULL
8	NULL
r=	NULL
0.77	NULL
sg	NULL
p	NULL
<	NULL
0.0001	NULL
3	NULL
(	NULL
3	NULL
3	NULL
cd	NULL
©	NULL
=	NULL
#	NULL
o	NULL
1	NULL
0	NULL
50	NULL
100	NULL
g	NULL
$	NULL
c	NULL
.	NULL

@	NULL
5	NULL
|	NULL
U	NULL
<	NULL
®	NULL
o	NULL
*	NULL
e	NULL
r=	NULL
0.67	NULL
3	NULL
&	NULL
p	NULL
<	NULL
0.0001	NULL
t	NULL
in	NULL
o	NULL
@	NULL
e	NULL
3	NULL
£	NULL
.	NULL

e	NULL
I	NULL
4	NULL
1	NULL
50	NULL
100	NULL
Epithelial	NULL
Stat1	NULL
Activation	NULL
(	NULL
%	NULL
epithelial	NULL
cells	NULL
with	NULL
nuclear	NULL
Stati	NULL
)	NULL
Figure	NULL
4	NULL
Stat1	NULL
activation	NULL
correlates	NULL
with	NULL
ICAM-1	NULL
and	NULL
Stat	NULL
!	NULL

expression	NULL
in	NULL
airway	NULL
epithelium	NULL
.	NULL

(	NULL
a-f	NULL
)	NULL
Representative	NULL
photomicrographs	NULL
of	NULL
endobronchial	NULL
biopsy	NULL
sections	NULL
from	NULL
control	NULL
(	NULL
a	NULL
and	NULL
d	NULL
)	NULL
,	NULL
asthma	NULL
(	NULL
b	NULL
and	NULL
e	NULL
)	NULL
,	NULL
and	NULL
chronic	NULL
bronchitis	NULL
(	NULL
e	NULL
and	NULL
f	NULL
)	NULL
subjects	NULL
immunostained	NULL
with	NULL
anti-lICAM-1	NULL
(	NULL
a-c	NULL
)	NULL
or	NULL
anti-Stat1	NULL
(	NULL
d-f	NULL
)	NULL
mAb	NULL
.	NULL

Primary	NULL
Ab	NULL
binding	NULL
was	NULL
detected	NULL
using	NULL
a	NULL
biotinylated	NULL
secondary	NULL
Ab	NULL
and	NULL
a	NULL
streptavidin-alkaline	NULL
phosphatase	NULL
complex	NULL
;	NULL
tissues	NULL
were	NULL
then	NULL
counterstained	NULL
with	NULL
hematoxylin	NULL
.	NULL

Control	NULL
staining	NULL
with	NULL
nonimmune	NULL
IgG	NULL
gave	NULL
no	NULL
detectable	NULL
signal	NULL
above	NULL
background	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Scale	NULL
bar	NULL
:	NULL
15	NULL
LM	NULL
.	NULL

(	NULL
g	NULL
and	NULL
h	NULL
)	NULL
Quantitative	NULL
analysis	NULL
of	NULL
Stat1	NULL
activation	NULL
versus	NULL
ICAM-1	NULL
(	NULL
g	NULL
)	NULL
and	NULL
Stat1	NULL
(	NULL
h	NULL
)	NULL
immunostaining	NULL
for	NULL
all	NULL
subjects	NULL
.	NULL

Values	NULL
for	NULL
the	NULL
percentage	NULL
of	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
containing	NULL
activated	NULL
(	NULL
translocated	NULL
)	NULL
Stat1	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
1	NULL
.	NULL

Values	NULL
for	NULL
ICAM-1	NULL
and	NULL
Stat1	NULL
immunostaining	NULL
were	NULL
derived	NULL
by	NULL
quantitating	NULL
the	NULL
red	NULL
intensity	NULL
of	NULL
epithelial	NULL
immunostaining	NULL
using	NULL
an	NULL
image	NULL
analysis	NULL
system	NULL
.	NULL

1358	NULL
Normally	NULL
low	NULL
airway	NULL
levels	NULL
of	NULL
IFN-Y	NULL
in	NULL
asthma	NULL
.	NULL

As	NULL
discussed	NULL
later	NULL
here	NULL
,	NULL
IFN-Y	NULL
is	NULL
the	NULL
only	NULL
cytokine	NULL
that	NULL
we	NULL
have	NULL
found	NULL
to	NULL
both	NULL
activate	NULL
Stat1	NULL
and	NULL
upregulate	NULL
ICAM-1	NULL
gene	NULL
expression	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Similarly	NULL
,	NULL
IFN-y	NULL
treatment	NULL
of	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
brushed	NULL
from	NULL
airways	NULL
of	NULL
normal	NULL
controls	NULL
display	NULL
increased	NULL
Statl	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
endobronchial	NULL
biopsies	NULL
of	NULL
these	NULL
subjects	NULL
exhibit	NULL
increased	NULL
Stat1	NULL
translocation	NULL
and	NULL
ICAM-1	NULL
expression	NULL
(	NULL
ref	NULL
.	NULL

14	NULL
;	NULL
Figure	NULL
2	NULL
,	NULL
c	NULL
and	NULL
f	NULL
;	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
questioned	NULL
whether	NULL
increased	NULL
levels	NULL
of	NULL
IFN-y	NULL
were	NULL
responsible	NULL
for	NULL
increases	NULL
in	NULL
airway	NULL
epithelial	NULL
Stat1	NULL
activation	NULL
and	NULL
Stat1-dependent	NULL
gene	NULL
expression	NULL
in	NULL
asthma	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
to	NULL
reports	NULL
by	NULL
others	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
indicated	NULL
no	NULL
evidence	NULL
of	NULL
increased	NULL
levels	NULL
of	NULL
IFN-y-expressing	NULL
immune	NULL
cells	NULL
in	NULL
asthmatic	NULL
subjects	NULL
(	NULL
Figure	NULL
5	NULL
,	NULL
c	NULL
and	NULL
d	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
number	NULL
of	NULL
immune	NULL
cells	NULL
capable	NULL
of	NULL
expressing	NULL
IFN-y	NULL
,	NULL
based	NULL
on	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
using	NULL
serial	NULL
sections	NULL
from	NULL
the	NULL
same	NULL
biopsies	NULL
after	NULL
ex	NULL
vivo	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
Figure	NULL
5	NULL
,	NULL
e	NULL
and	NULL
£	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
airway	NULL
tissue	NULL
levels	NULL
of	NULL
IFN-y	NULL
mRNA	NULL
(	NULL
in	NULL
contrast	NULL
to	NULL
IL-4	NULL
)	NULL
were	NULL
similarly	NULL
low	NULL
in	NULL
normal	NULL
control	NULL
and	NULL
asthmatic	NULL
subjects	NULL
(	NULL
Figure	NULL
5	NULL
,	NULL
g	NULL
and	NULL
h	NULL
)	NULL
.	NULL

As	NULL
discussed	NULL
later	NULL
here	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
a	NULL
constitutive	NULL
abnormality	NULL
in	NULL
IFN-y-dependent	NULL
signal	NULL
transduction	NULL
and	NULL
gene	NULL
expression	NULL
that	NULL
does	NULL
not	NULL
necessarily	NULL
depend	NULL
on	NULL
abnormal	NULL
production	NULL
of	NULL
IFN-y	NULL
itself	NULL
.	NULL

Discussion	NULL
Constitutive	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
may	NULL
be	NULL
found	NULL
during	NULL
abnormal	NULL
proliferation	NULL
of	NULL
cells	NULL
,	NULL
especially	NULL
malignant	NULL
transformation	NULL
of	NULL
immune	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
endogenous	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
of	NULL
oncopro-teins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
constitutive	NULL
activity	NULL
of	NULL
cytokine	NULL
receptors	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|	NULL
Number	NULL
9	NULL
or	NULL
receptor-associated	NULL
Janus	NULL
kinases	NULL
(	NULL
Jaks	NULL
)	NULL
,	NULL
has	NULL
driven	NULL
STAT	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
abnormalities	NULL
in	NULL
the	NULL
Jak-STAT	NULL
pathway	NULL
for	NULL
cytokine	NULL
signal	NULL
transduction	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
diseases	NULL
due	NULL
to	NULL
abnormal	NULL
cell	NULL
growth	NULL
,	NULL
but	NULL
an	NULL
abnormality	NULL
in	NULL
this	NULL
(	NULL
or	NULL
any	NULL
other	NULL
)	NULL
pathway	NULL
for	NULL
cytokine	NULL
signaling	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
linked	NULL
to	NULL
the	NULL
development	NULL
of	NULL
inflammatory	NULL
disease	NULL
.	NULL

Our	NULL
results	NULL
therefore	NULL
provide	NULL
initial	NULL
evidence	NULL
for	NULL
an	NULL
abnormality	NULL
in	NULL
a	NULL
pathway	NULL
for	NULL
cytokine	NULL
signal	NULL
transduction	NULL
(	NULL
as	NULL
opposed	NULL
to	NULL
altered	NULL
cytokine	NULL
production	NULL
)	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
an	NULL
inflammatory	NULL
disease	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
Stat1	NULL
transcription	NULL
factor	NULL
is	NULL
selectively	NULL
activated	NULL
in	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
of	NULL
asthmatic	NULL
subjects	NULL
.	NULL

The	NULL
abnormality	NULL
appears	NULL
selective	NULL
because	NULL
it	NULL
is	NULL
not	NULL
found	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
Stat3	NULL
,	NULL
NF-KB	NULL
,	NULL
or	NULL
AP-1	NULL
)	NULL
and	NULL
is	NULL
not	NULL
present	NULL
in	NULL
other	NULL
neighboring	NULL
cell	NULL
types	NULL
or	NULL
in	NULL
subjects	NULL
with	NULL
another	NULL
form	NULL
of	NULL
chronic	NULL
airway	NULL
inflammation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
find	NULL
that	NULL
epithelial	NULL
Stat1	NULL
activity	NULL
corresponded	NULL
closely	NULL
with	NULL
increased	NULL
expression	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
:	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
identical	NULL
to	NULL
the	NULL
profile	NULL
of	NULL
Stat1	NULL
activation	NULL
and	NULL
Stat1-dependent	NULL
gene	NULL
expression	NULL
triggered	NULL
by	NULL
IFN-y	NULL
signal	NULL
transduction	NULL
in	NULL
isolated	NULL
human	NULL
airway	NULL
epithelial	NULL
cells	NULL
and	NULL
endobronchial	NULL
explants	NULL
and	NULL
in	NULL
mouse	NULL
models	NULL
of	NULL
airway	NULL
inflammation	NULL
(	NULL
refs	NULL
.	NULL

15-24	NULL
,	NULL
and	NULL
our	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
IFN-y-receptor	NULL
complex	NULL
leads	NULL
to	NULL
Stat1	NULL
phosphorylation	NULL
,	NULL
dimeriza-tion	NULL
,	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
consequent	NULL
binding	NULL
to	NULL
genetic	NULL
targets	NULL
(	NULL
typified	NULL
by	NULL
the	NULL
11-bp	NULL
inverted	NULL
repeat	NULL
in	NULL
the	NULL
ICAM-1	NULL
gene	NULL
promoter	NULL
region	NULL
)	NULL
that	NULL
enhances	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
asthma	NULL
,	NULL
however	NULL
,	NULL
Stat	NULL
1	NULL
activation	NULL
is	NULL
detected	NULL
in	NULL
the	NULL
apparent	NULL
absence	NULL
of	NULL
augmented	NULL
tissue	NULL
levels	NULL
of	NULL
IFN-y	NULL
(	NULL
present	NULL
results	NULL
,	NULL
and	NULL
refs	NULL
.	NULL

8-10	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
asthma	NULL
appears	NULL
to	NULL
exhibit	NULL
an	NULL
abnormality	NULL
in	NULL
the	NULL
pathway	NULL
for	NULL
cytokine	NULL
signal	NULL
transduction	NULL
that	NULL
leads	NULL
to	NULL
Stat1	NULL
activation	NULL
and	NULL
enhanced	NULL
expression	NULL
of	NULL
epithelial	NULL
ICAM-1	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
Stat1	NULL
itself	NULL
.	NULL

As	NULL
discussed	NULL
later	NULL
here	NULL
,	NULL
this	NULL
pathway	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
cell	NULL
adhesion	NULL
molecule	NULL
ICAM-1	NULL
(	NULL
in	NULL
concert	NULL
with	NULL
its	NULL
chemokine	NULL
partner	NULL
,	NULL
RANTES	NULL
)	NULL
may	NULL
mediate	NULL
recruitment	NULL
and	NULL
activation	NULL
of	NULL
immune	NULL
cells	NULL
by	NULL
the	NULL
airway	NULL
epithelium	NULL
(	NULL
14	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
22	NULL
)	NULL
,	NULL
whereas	NULL
autoamplification	NULL
of	NULL
Statl	NULL
action	NULL
may	NULL
further	NULL
predispose	NULL
asthmatic	NULL
subjects	NULL
to	NULL
excessive	NULL
airway	NULL
inflammation	NULL
and	NULL
consequent	NULL
end-organ	NULL
dysfunction	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IRF-1	NULL
in	NULL
causing	NULL
epithelial	NULL
gene	NULL
expression	NULL
is	NULL
still	NULL
uncertain	NULL
,	NULL
but	NULL
expression	NULL
of	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
(	NULL
iNOS	NULL
)	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
responsive	NULL
to	NULL
IFN-y	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
the	NULL
characteristics	NULL
of	NULL
this	NULL
response	NULL
indicate	NULL
that	NULL
it	NULL
may	NULL
depend	NULL
(	NULL
as	NULL
it	NULL
does	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
)	NULL
on	NULL
induction	NULL
of	NULL
IRF-1	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
IFN-y-inducible	NULL
iNOS	NULL
gene	NULL
expression	NULL
can	NULL
be	NULL
augmented	NULL
by	NULL
IL-4	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
Stat1	NULL
activation	NULL
(	NULL
and	NULL
consequent	NULL
IRF-1	NULL
expression	NULL
)	NULL
and	NULL
IL-4	NULL
production	NULL
may	NULL
explain	NULL
increased	NULL
iNOS	NULL
gene	NULL
expression	NULL
in	NULL
asthma	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Localizing	NULL
the	NULL
abnormality	NULL
in	NULL
Stat1	NULL
activity	NULL
to	NULL
airway	NULL
epithelial	NULL
cells	NULL
is	NULL
critical	NULL
to	NULL
the	NULL
impact	NULL
of	NULL
the	NULL
present	NULL
findings	NULL
.	NULL

As	NULL
already	NULL
noted	NULL
here	NULL
,	NULL
constitutive	NULL
STAT	NULL
activities	NULL
in	NULL
lymphocytes	NULL
are	NULL
associated	NULL
with	NULL
malignant	NULL
trans-formation	NULL
,	NULL
whereas	NULL
excessive	NULL
Stat1	NULL
activity	NULL
in	NULL
chondro-cytes	NULL
driven	NULL
by	NULL
a	NULL
mutant	NULL
fibroblast	NULL
growth	NULL
factor	NULL
receptor	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
growth	NULL
arrest	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Normal	NULL
Control	NULL
Asthma	NULL
a	NULL
_.	NULL
ﬁg	NULL
a	NULL
*	NULL
``	NULL
b	NULL
£	NULL
.	NULL

aig	NULL
*	NULL
1	NULL
.	NULL

€	NULL
«	NULL
'	NULL
.	NULL

#	NULL
%	NULL
$	NULL
’	NULL
-ﬁ	NULL
``	NULL
-	NULL
&	NULL
‘	NULL
_	NULL
``	NULL
'	NULL
?	NULL

_r	NULL
cos	NULL
_	NULL
>	NULL
a_	NULL
``	NULL
~*	NULL
4	NULL
%	NULL
,	NULL
.	NULL

%	NULL
:	NULL
*	NULL
%	NULL
__	NULL
&	NULL
``	NULL
ag	NULL
&	NULL
A	NULL
as	NULL
O	NULL
*	NULL
&	NULL
``	NULL
h	NULL
»	NULL
‘	NULL
-	NULL
IFN-y	NULL
IFN-y	NULL
after	NULL
PMA/A	NULL
g	NULL
Normal	NULL
Control	NULL
Asthma	NULL
PBMC	NULL
IFN-y	NULL
>	NULL
IL-4	NULL
>	NULL
h	NULL
IFN	NULL
;	NULL
>	NULL
--	NULL
..-	NULL
.	NULL

pocin	NULL
>	NULL
Cn	NULL
aan	NULL
aan	NULL
ap	NULL
ap	NULL
ap	NULL
CD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Figure	NULL
5	NULL
Increased	NULL
levels	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
normal	NULL
levels	NULL
of	NULL
IFN-y	NULL
expression	NULL
in	NULL
asthma	NULL
.	NULL

(	NULL
af	NULL
)	NULL
Representative	NULL
photomicrographs	NULL
of	NULL
endobronchial	NULL
biopsy	NULL
sections	NULL
from	NULL
a	NULL
representative	NULL
control	NULL
(	NULL
a	NULL
,	NULL
d	NULL
,	NULL
and	NULL
e	NULL
)	NULL
and	NULL
asthma	NULL
(	NULL
b	NULL
,	NULL
¢	NULL
,	NULL
and	NULL
f	NULL
)	NULL
subject	NULL
after	NULL
immunostaining	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
a	NULL
and	NULL
b	NULL
)	NULL
and	NULL
after	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
3°S-labeled	NULL
IFN-y	NULL
cRNA	NULL
using	NULL
unstimulated	NULL
(	NULL
e	NULL
and	NULL
d	NULL
)	NULL
or	NULL
PMA/ionomycin-stimulated	NULL
(	NULL
e	NULL
and	NULL
£	NULL
)	NULL
biopsies	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
hybridization	NULL
with	NULL
3°S-labeled	NULL
IFN-y	NULL
RNA	NULL
(	NULL
sense	NULL
probe	NULL
)	NULL
gave	NULL
no	NULL
detectable	NULL
signal	NULL
above	NULL
background	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
cells	NULL
expressing	NULL
IFN-4	NULL
mRNA	NULL
.	NULL

Scale	NULL
bar	NULL
:	NULL
15	NULL
LM	NULL
.	NULL

(	NULL
g	NULL
and	NULL
h	NULL
)	NULL
Representative	NULL
results	NULL
of	NULL
RT-PCR	NULL
from	NULL
endobronchial	NULL
tissue	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
and	NULL
from	NULL
PMA/ionomycin-stimulated	NULL
PMBCs	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
using	NULL
oligonucleotide	NULL
primers	NULL
for	NULL
IFN-y	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
B-actin	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
subjected	NULL
to	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
then	NULL
detected	NULL
using	NULL
ethidium	NULL
bromide	NULL
staining	NULL
(	NULL
g	NULL
)	NULL
or	NULL
subsequent	NULL
Southern	NULL
blotting	NULL
with	NULL
*2P-labeled	NULL
cDNA	NULL
probes	NULL
(	NULL
h	NULL
)	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|	NULL
Number9	NULL
1359	NULL
1360	NULL
depending	NULL
on	NULL
the	NULL
programmed	NULL
cytokine	NULL
response	NULL
of	NULL
specific	NULL
cell	NULL
types	NULL
in	NULL
specific	NULL
tissues	NULL
,	NULL
abnormal	NULL
Jak-STAT	NULL
activity	NULL
may	NULL
lead	NULL
to	NULL
diseases	NULL
as	NULL
diverse	NULL
as	NULL
lymphoma	NULL
or	NULL
dwarfism	NULL
.	NULL

Consequently	NULL
,	NULL
analysis	NULL
of	NULL
cytokine-dependent	NULL
responses	NULL
in	NULL
asthma	NULL
using	NULL
sites	NULL
distant	NULL
from	NULL
the	NULL
airways	NULL
may	NULL
not	NULL
reflect	NULL
behavior	NULL
in	NULL
airway	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
others	NULL
have	NULL
indicated	NULL
that	NULL
decreased	NULL
Th1	NULL
responses	NULL
may	NULL
predispose	NULL
to	NULL
asthma	NULL
,	NULL
based	NULL
on	NULL
an	NULL
association	NULL
with	NULL
diminished	NULL
delayed-type	NULL
hypersensitivity	NULL
reactions	NULL
to	NULL
tuberculin	NULL
(	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
association	NULL
was	NULL
based	NULL
on	NULL
immune	NULL
responses	NULL
in	NULL
the	NULL
skin	NULL
and	NULL
thus	NULL
does	NULL
not	NULL
reflect	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
Th1-driven	NULL
signaling	NULL
pathways	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
.	NULL

The	NULL
mechanism	NULL
that	NULL
underlies	NULL
activation	NULL
of	NULL
Stat1	NULL
in	NULL
asthma	NULL
is	NULL
uncertain	NULL
,	NULL
but	NULL
several	NULL
possibilities	NULL
have	NULL
been	NULL
addressed	NULL
by	NULL
our	NULL
work	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
excluded	NULL
(	NULL
as	NULL
much	NULL
as	NULL
possible	NULL
)	NULL
overproduction	NULL
of	NULL
IFN-Y	NULL
as	NULL
a	NULL
basis	NULL
for	NULL
activation	NULL
of	NULL
epithelial	NULL
Stat1	NULL
.	NULL

As	NULL
already	NULL
noted	NULL
here	NULL
,	NULL
our	NULL
findings	NULL
extend	NULL
results	NULL
by	NULL
others	NULL
that	NULL
IFN-y	NULL
levels	NULL
are	NULL
not	NULL
increased	NULL
(	NULL
and	NULL
may	NULL
even	NULL
be	NULL
decreased	NULL
)	NULL
in	NULL
asthmatic	NULL
subjects	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

The	NULL
few	NULL
reports	NULL
of	NULL
IFN-y	NULL
overproduction	NULL
in	NULL
asthma	NULL
may	NULL
well	NULL
reflect	NULL
the	NULL
partial	NULL
overlap	NULL
between	NULL
Th1	NULL
and	NULL
Th2	NULL
phenotypes	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
likely	NULL
possibility	NULL
that	NULL
both	NULL
types	NULL
of	NULL
cytokines	NULL
are	NULL
generated	NULL
in	NULL
some	NULL
asthmatic	NULL
subjects	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
excess	NULL
IFN-y	NULL
in	NULL
asthma	NULL
,	NULL
we	NULL
have	NULL
screened	NULL
for	NULL
other	NULL
cytokines	NULL
that	NULL
might	NULL
activate	NULL
Stat1	NULL
and	NULL
induce	NULL
ICAM-1	NULL
and	NULL
Stat1	NULL
expression	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
,	NULL
but	NULL
we	NULL
find	NULL
that	NULL
,	NULL
among	NULL
other	NULL
known	NULL
Stat1	NULL
activators	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
only	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B	NULL
is	NULL
effective	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
(	NULL
15-19	NULL
,	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IFEN-0/fB	NULL
activates	NULL
genes	NULL
by	NULL
formation	NULL
of	NULL
a	NULL
Stat1/Stat2/p48	NULL
complex	NULL
(	NULL
1	NULL
)	NULL
and	NULL
so	NULL
can	NULL
not	NULL
induce	NULL
ICAM-1	NULL
gene	NULL
expression	NULL
,	NULL
which	NULL
requires	NULL
a	NULL
Stat1/Stat1	NULL
complex	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
present	NULL
experiments	NULL
,	NULL
we	NULL
would	NULL
not	NULL
expect	NULL
IFN-0/f	NULL
in	NULL
the	NULL
airway	NULL
epithelium	NULL
,	NULL
as	NULL
viral	NULL
infection	NULL
was	NULL
excluded	NULL
in	NULL
our	NULL
subjects	NULL
.	NULL

Similarly	NULL
,	NULL
production	NULL
of	NULL
IFN-	NULL
@	NULL
/fB	NULL
(	NULL
or	NULL
other	NULL
cytokines	NULL
)	NULL
would	NULL
not	NULL
likely	NULL
cause	NULL
activation	NULL
of	NULL
Statl	NULL
selectively	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
without	NULL
affecting	NULL
neighboring	NULL
cell	NULL
types	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
Stat1	NULL
in	NULL
asthma	NULL
may	NULL
be	NULL
due	NULL
to	NULL
overproduction	NULL
of	NULL
cytokine	NULL
,	NULL
but	NULL
current	NULL
evidence	NULL
favors	NULL
an	NULL
intrinsic	NULL
abnormality	NULL
in	NULL
the	NULL
epithelial	NULL
Stat1	NULL
pathway	NULL
for	NULL
cytokine	NULL
signal	NULL
transduction	NULL
(	NULL
analogous	NULL
to	NULL
those	NULL
found	NULL
during	NULL
altered	NULL
cell	NULL
growth	NULL
)	NULL
.	NULL

In	NULL
that	NULL
regard	NULL
,	NULL
we	NULL
have	NULL
further	NULL
excluded	NULL
the	NULL
possibility	NULL
that	NULL
asthmatic	NULL
subjects	NULL
have	NULL
the	NULL
Stat1	NULL
truncation	NULL
that	NULL
augments	NULL
Stat1l	NULL
phosphorylation	NULL
(	NULL
36	NULL
)	NULL
,	NULL
as	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
the	NULL
expected	NULL
change	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
this	NULL
mutant	NULL
Stat1	NULL
.	NULL

More	NULL
subtle	NULL
structural	NULL
alterations	NULL
in	NULL
Stat1	NULL
or	NULL
in	NULL
proteins	NULL
that	NULL
modify	NULL
its	NULL
phosphorylation	NULL
state	NULL
are	NULL
under	NULL
study	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cell-specific	NULL
nature	NULL
of	NULL
the	NULL
Stat1	NULL
abnormality	NULL
in	NULL
asthma	NULL
indicates	NULL
that	NULL
an	NULL
inherited	NULL
or	NULL
acquired	NULL
abnormality	NULL
is	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
found	NULL
in	NULL
a	NULL
regulatory	NULL
molecule	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
kinase	NULL
or	NULL
phos-phatase	NULL
)	NULL
that	NULL
is	NULL
expressed	NULL
or	NULL
activated	NULL
selectively	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
or	NULL
is	NULL
altered	NULL
selectively	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
by	NULL
viral	NULL
infection	NULL
)	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
provide	NULL
initial	NULL
evidence	NULL
for	NULL
a	NULL
fundamental	NULL
abnormality	NULL
distinct	NULL
from	NULL
those	NULL
previously	NULL
invoked	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
asthma	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
find	NULL
selective	NULL
activity	NULL
of	NULL
epithelial	NULL
Stat1	NULL
through	NULL
a	NULL
pathway	NULL
that	NULL
normally	NULL
responds	NULL
to	NULL
production	NULL
of	NULL
the	NULL
Th1	NULL
cytokine	NULL
IFN-y	NULL
.	NULL

This	NULL
constitutive	NULL
Stat1	NULL
signal	NULL
may	NULL
lead	NULL
to	NULL
overexpression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
epithelial	NULL
immune-response	NULL
genes	NULL
,	NULL
including	NULL
ICAM-1	NULL
,	NULL
Statl1	NULL
,	NULL
and	NULL
IRF-1	NULL
transcription	NULL
factor	NULL
(	NULL
15-18	NULL
,	NULL
23	NULL
)	NULL
,	NULL
and	NULL
a	NULL
condition	NULL
of	NULL
persistent	NULL
immune	NULL
activation	NULL
.	NULL

This	NULL
mechanism	NULL
for	NULL
regulating	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
is	NULL
complemented	NULL
by	NULL
regulation	NULL
at	NULL
the	NULL
posttranscriptional	NULL
level	NULL
for	NULL
some	NULL
epithelial	NULL
immune-response	NULL
genes	NULL
.	NULL

For	NULL
example	NULL
,	NULL
epithelial	NULL
RANTES	NULL
gene	NULL
expression	NULL
depends	NULL
on	NULL
rRNA	NULL
stabilization	NULL
that	NULL
is	NULL
inducible	NULL
directly	NULL
by	NULL
respiratory	NULL
virus	NULL
(	NULL
25	NULL
)	NULL
and	NULL
indirectly	NULL
by	NULL
virus-triggered	NULL
IFN-y	NULL
production	NULL
(	NULL
39	NULL
)	NULL
or	NULL
perhaps	NULL
other	NULL
endogenous	NULL
stimuli	NULL
that	NULL
exacerbate	NULL
asthma	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
it	NULL
appears	NULL
likely	NULL
that	NULL
activation	NULL
and	NULL
consequent	NULL
overexpression	NULL
of	NULL
Statl	NULL
may	NULL
predispose	NULL
asthmatic	NULL
subjects	NULL
to	NULL
excessive	NULL
airway	NULL
inflammation	NULL
in	NULL
response	NULL
to	NULL
any	NULL
increases	NULL
in	NULL
IFN-y	NULL
pro-duction	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
during	NULL
viral	NULL
infection	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
experiments	NULL
with	NULL
isolated	NULL
cells	NULL
indicate	NULL
that	NULL
the	NULL
level	NULL
of	NULL
cellular	NULL
Stat1	NULL
(	NULL
as	NULL
well	NULL
as	NULL
its	NULL
activation	NULL
status	NULL
)	NULL
serves	NULL
to	NULL
regulate	NULL
the	NULL
level	NULL
of	NULL
Stat1-dependent	NULL
gene	NULL
expression	NULL
(	NULL
23	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Our	NULL
present	NULL
findings	NULL
therefore	NULL
offer	NULL
an	NULL
alternative	NULL
pathway	NULL
for	NULL
airway	NULL
inflammation	NULL
in	NULL
asthma	NULL
that	NULL
is	NULL
based	NULL
on	NULL
Th1-type	NULL
cytokine	NULL
signaling	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
and	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
excessive	NULL
Th2	NULL
cytokine	NULL
production	NULL
from	NULL
immune	NULL
cells	NULL
invoked	NULL
for	NULL
allergy-driven	NULL
disease	NULL
.	NULL

Interaction	NULL
between	NULL
these	NULL
Th1-	NULL
and	NULL
Th2-based	NULL
pathways	NULL
may	NULL
combine	NULL
to	NULL
cause	NULL
an	NULL
excessive	NULL
inflammatory	NULL
response	NULL
to	NULL
inhaled	NULL
stimuli	NULL
by	NULL
providing	NULL
for	NULL
increased	NULL
recruitment	NULL
and	NULL
retention	NULL
of	NULL
immune	NULL
cells	NULL
along	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
allergen	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
gratefully	NULL
acknowledge	NULL
valuable	NULL
help	NULL
from	NULL
Yael	NULL
Gris-Alevy	NULL
,	NULL
Michelle	NULL
Jenkerson	NULL
,	NULL
Bill	NULL
Parks	NULL
,	NULL
Jill	NULL
Roby	NULL
,	NULL
Bill	NULL
Roswit	NULL
,	NULL
Ken	NULL
Schechtman	NULL
,	NULL
Theresa	NULL
Tolley	NULL
,	NULL
and	NULL
Nina	NULL
Zimmerman	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
the	NULL
Alan	NULL
A.	NULL
and	NULL
Edith	NULL
L.	NULL
Wolff	NULL
Charitable	NULL
Trust	NULL
.	NULL

1	NULL
.	NULL

Darnell	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
Jr.	NULL
1997	NULL
.	NULL

STAT	NULL
's	NULL
and	NULL
gene	NULL
regulation	NULL
.	NULL

Science	NULL
.	NULL

277:1630-1635	NULL
.	NULL

2.O'Shea	NULL
,	NULL
JJ	NULL
.	NULL

1997	NULL
.	NULL

Jaks	NULL
,	NULL
STATs	NULL
,	NULL
cytokine	NULL
signal	NULL
transduction	NULL
,	NULL
and	NULL
immunoregulation	NULL
:	NULL
are	NULL
we	NULL
there	NULL
yet	NULL
?	NULL

Immunity	NULL
.	NULL

7:1-11	NULL
.	NULL

3	NULL
.	NULL

Bousquet	NULL
,	NULL
J.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
.	NULL

Eosinophilic	NULL
inflammation	NULL
in	NULL
asthma	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

323:1033-1039	NULL
.	NULL

4	NULL
.	NULL

Burrows	NULL
,	NULL
B.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

Association	NULL
of	NULL
asthma	NULL
with	NULL
serum	NULL
IgE	NULL
levels	NULL
and	NULL
skin-test	NULL
reactivity	NULL
to	NULL
allergens	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

320:27	NULL
1-277	NULL
.	NULL

5	NULL
.	NULL

Shirakawa	NULL
,	NULL
T.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Association	NULL
between	NULL
atopy	NULL
and	NULL
variants	NULL
of	NULL
the	NULL
B	NULL
subunit	NULL
of	NULL
the	NULL
high-affinity	NULL
immunoglobulin	NULL
E	NULL
receptor	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

7:125-130	NULL
.	NULL

6	NULL
.	NULL

Marsh	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Linkage	NULL
analysis	NULL
of	NULL
IL4	NULL
and	NULL
other	NULL
chromosome	NULL
5q31.1	NULL
markers	NULL
and	NULL
total	NULL
serum	NULL
immunoglobulin	NULL
E	NULL
concentrations	NULL
.	NULL

Science	NULL
.	NULL

264:1152-1156	NULL
.	NULL

7	NULL
.	NULL

Hershey	NULL
,	NULL
G.K.	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
association	NULL
of	NULL
atopy	NULL
with	NULL
a	NULL
gain-of-func-tion	NULL
mutation	NULL
in	NULL
the	NULL
&	NULL
subunit	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

337:1720-1725	NULL
.	NULL

8	NULL
.	NULL

Robinson	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
.	NULL

Predominant	NULL
bronchoalveolar	NULL
T-lymphocyte	NULL
population	NULL
in	NULL
atopic	NULL
asthma	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

326:298-304	NULL
.	NULL

9	NULL
.	NULL

Ying	NULL
,	NULL
S.	NULL
,	NULL
Durham	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Corrigan	NULL
,	NULL
CJ	NULL
.	NULL

,	NULL
Hamid	NULL
,	NULL
Q.	NULL
,	NULL
and	NULL
Kay	NULL
,	NULL
A.B	NULL
.	NULL

1995	NULL
.	NULL

Phenotype	NULL
of	NULL
cells	NULL
expressing	NULL
mRNA	NULL
for	NULL
TH2-type	NULL
(	NULL
interleukin	NULL
4	NULL
and	NULL
interleukin	NULL
5	NULL
)	NULL
and	NULL
TH1-type	NULL
(	NULL
interleukin	NULL
2	NULL
and	NULL
interferon	NULL
Y	NULL
)	NULL
cytokines	NULL
in	NULL
bronchoalveolar	NULL
lavage	NULL
and	NULL
bronchial	NULL
biopsies	NULL
from	NULL
atopic	NULL
asthmatic	NULL
and	NULL
normal	NULL
control	NULL
subjects	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

12:477-487	NULL
.	NULL

10.	NULL
van	NULL
der	NULL
Pouw	NULL
Kraan	NULL
,	NULL
T.C.T.M	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Reduced	NULL
production	NULL
of	NULL
IL-12	NULL
and	NULL
IL-12-dependent	NULL
IFN-Y	NULL
release	NULL
in	NULL
patients	NULL
with	NULL
allergic	NULL
asthma	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5560-5565	NULL
.	NULL

11	NULL
.	NULL

Shirakawa	NULL
,	NULL
T.	NULL
,	NULL
Enomoto	NULL
,	NULL
T.	NULL
,	NULL
Shimazu	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Hopkin	NULL
,	NULL
J.M	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
inverse	NULL
association	NULL
between	NULL
tuberculin	NULL
responses	NULL
and	NULL
atopic	NULL
disorders	NULL
.	NULL

Science	NULL
.	NULL

275:77-79	NULL
.	NULL

12	NULL
.	NULL

Holtzman	NULL
,	NULL
M.J.	NULL
,	NULL
Sampath	NULL
,	NULL
D.	NULL
,	NULL
Castro	NULL
,	NULL
M.	NULL
,	NULL
Look	NULL
,	NULL
D.C.	NULL
,	NULL
and	NULL
Jayaraman	NULL
,	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
one-two	NULL
of	NULL
T	NULL
helper	NULL
cells	NULL
:	NULL
does	NULL
interferon-y	NULL
knockout	NULL
the	NULL
Th2	NULL
hypothesis	NULL
for	NULL
asthma	NULL
?	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

14:316-318	NULL
.	NULL

13	NULL
.	NULL

Holtzman	NULL
,	NULL
MJ	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Control	NULL
of	NULL
epithelial	NULL
immune-response	NULL
genes	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|	NULL
Number	NULL
9	NULL
and	NULL
implications	NULL
for	NULL
airway	NULL
immunity	NULL
and	NULL
inflammation	NULL
.	NULL

Proc	NULL
.	NULL

Assoc	NULL
.	NULL

Am	NULL
.	NULL

Physicians	NULL
.	NULL

110:1-11	NULL
.	NULL

14	NULL
.	NULL

Taguchi	NULL
,	NULL
M.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Patterns	NULL
for	NULL
RANTES	NULL
secretion	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
expression	NULL
mediate	NULL
transepithelial	NULL
T	NULL
cell	NULL
traffic	NULL
based	NULL
on	NULL
analyses	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1927-1940	NULL
.	NULL

15	NULL
.	NULL

Look	NULL
,	NULL
D.C.	NULL
,	NULL
Pelletier	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1994	NULL
.	NULL

Selective	NULL
interaction	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
interferon-y	NULL
response	NULL
element	NULL
binding	NULL
proteins	NULL
with	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
gene	NULL
promoter	NULL
controls	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
on	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:8952-8958	NULL
.	NULL

16	NULL
.	NULL

Look	NULL
,	NULL
D.C.	NULL
,	NULL
Pelletier	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Tidwell	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Roswit	NULL
,	NULL
W.T	NULL
.	NULL

,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1995	NULL
.	NULL

Stat1	NULL
depends	NULL
on	NULL
transcriptional	NULL
synergy	NULL
with	NULL
SpL	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:30264-30267	NULL
.	NULL

17	NULL
.	NULL

Walter	NULL
,	NULL
MJ	NULL
.	NULL

,	NULL
Look	NULL
,	NULL
D.C.	NULL
,	NULL
Tidwell	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Roswit	NULL
,	NULL
W.T	NULL
.	NULL

,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1997	NULL
.	NULL

Targeted	NULL
inhibition	NULL
of	NULL
interferon-y-dependent	NULL
ICAM-1	NULL
expression	NULL
using	NULL
dominant-negative	NULL
StatL	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:28582-28589	NULL
.	NULL

18	NULL
.	NULL

Look	NULL
,	NULL
D.C.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Direct	NULL
suppression	NULL
of	NULL
Stat1	NULL
function	NULL
during	NULL
ade-noviral	NULL
infection	NULL
.	NULL

Immunity	NULL
.	NULL

9:87	NULL
1-880	NULL
.	NULL

19	NULL
.	NULL

Nakajima	NULL
,	NULL
S.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Selective	NULL
differences	NULL
in	NULL
vascular	NULL
endothelial	NULL
vs.	NULL
airway	NULL
epithelial-T	NULL
cell	NULL
adhesion	NULL
mechanisms	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

267:1422-L432	NULL
.	NULL

20	NULL
.	NULL

Nakajima	NULL
,	NULL
S.	NULL
,	NULL
Roswit	NULL
,	NULL
W.T	NULL
.	NULL

,	NULL
Look	NULL
,	NULL
D.C.	NULL
,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1995	NULL
.	NULL

A	NULL
hierarchy	NULL
for	NULL
integrin	NULL
expression	NULL
and	NULL
adhesiveness	NULL
among	NULL
T	NULL
cell	NULL
subsets	NULL
that	NULL
is	NULL
linked	NULL
to	NULL
TCR	NULL
gene	NULL
usage	NULL
and	NULL
emphasizes	NULL
46	NULL
T	NULL
cell	NULL
adherence	NULL
and	NULL
tissue	NULL
retention	NULL
.	NULL

J	NULL
.	NULL

15§:1117-1131.	NULL
.	NULL

Holtzman	NULL
,	NULL
M.J.	NULL
,	NULL
Castro	NULL
,	NULL
M.	NULL
,	NULL
Look	NULL
,	NULL
D.C.	NULL
,	NULL
O'Sullivan	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Walter	NULL
,	NULL
M.J.	NULL
1999	NULL
.	NULL

Regulation	NULL
of	NULL
epithelial-leukocyte	NULL
interaction	NULL
and	NULL
epithelial	NULL
immune-response	NULL
genes	NULL
.	NULL

In	NULL
Asthma	NULL
and	NULL
rhinitis	NULL
.	NULL

W.	NULL
Busse	NULL
and	NULL
S.	NULL
Holgate	NULL
,	NULL
editors	NULL
.	NULL

Blackwell	NULL
Scientific	NULL
.	NULL

Cambridge	NULL
,	NULL
MA	NULL
.	NULL

In	NULL
press	NULL
.	NULL

22	NULL
.	NULL

Look	NULL
,	NULL
D.C.	NULL
,	NULL
Keller	NULL
,	NULL
B.T	NULL
.	NULL

,	NULL
Rapp	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1992	NULL
.	NULL

Selective	NULL
induction	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
by	NULL
interferon-¥	NULL
in	NULL
human	NULL
airway	NULL
epithelial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

263	NULL
:	NULL
L79-L87	NULL
.	NULL

23	NULL
.	NULL

Sampath	NULL
,	NULL
D.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Autoamplification	NULL
of	NULL
Stat1l-dependent	NULL
gene	NULL
expression	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

12	NULL
:	NULL
A1390	NULL
.	NULL

(	NULL
Abstr	NULL
.	NULL
)	NULL

24	NULL
.	NULL

Walter	NULL
,	NULL
MJ	NULL
.	NULL

,	NULL
Kajiwara	NULL
,	NULL
N.	NULL
,	NULL
Sampath	NULL
,	NULL
D.	NULL
,	NULL
Rucker	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1998	NULL
.	NULL

Induction	NULL
of	NULL
epithelial	NULL
immune-response	NULL
genes	NULL
in	NULL
a	NULL
mouse	NULL
model	NULL
of	NULL
viral	NULL
bronchitis	NULL
and	NULL
hyperreactivity	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

12:1453	NULL
.	NULL

25	NULL
.	NULL

Koga	NULL
,	NULL
T.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1999	NULL
.	NULL

Virus-inducible	NULL
expression	NULL
of	NULL
a	NULL
host	NULL
chemokine	NULL
gene	NULL
relies	NULL
on	NULL
replication-linked	NULL
mRNA	NULL
stabilization	NULL
.	NULL

Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

In	NULL
press	NULL
.	NULL

2	NULL
o	NULL
26	NULL
.	NULL

Meneely	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
Renzetti	NULL
,	NULL
A.D.	NULL
,	NULL
Jr.	NULL
,	NULL
Steele	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Wyatt	NULL
,	NULL
J.P.	NULL
,	NULL
and	NULL
Harris	NULL
,	NULL
H.W	NULL
.	NULL

1962	NULL
.	NULL

Definitions	NULL
and	NULL
classification	NULL
of	NULL
chronic	NULL
bronchitis	NULL
,	NULL
asthma	NULL
,	NULL
and	NULL
pulmonary	NULL
emphysema	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

85:762-768	NULL
.	NULL

27	NULL
.	NULL

Bigby	NULL
,	NULL
T.D	NULL
.	NULL

,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1987	NULL
.	NULL

Enhanced	NULL
S5-lipoxygenase	NULL
activity	NULL
in	NULL
pulmonary	NULL
macrophages	NULL
compared	NULL
to	NULL
monocytes	NULL
from	NULL
normal	NULL
subjects	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:1546-1550	NULL
.	NULL

28	NULL
.	NULL

Kaptein	NULL
,	NULL
A.	NULL
,	NULL
Paillard	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Saunders	NULL
,	NULL
M.	NULL
1996	NULL
.	NULL

Dominant	NULL
negative	NULL
Stat3	NULL
mutant	NULL
inhibits	NULL
interleukin-6-induced	NULL
Jak-STAT	NULL
signal	NULL
trans-duction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:5961-5964	NULL
.	NULL

29	NULL
.	NULL

Broide	NULL
,	NULL
D.H.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
.	NULL

Cytokines	NULL
in	NULL
symptomatic	NULL
asthma	NULL
airways	NULL
.	NULL

J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

89:958-967	NULL
.	NULL

30	NULL
.	NULL

Demoly	NULL
,	NULL
P.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1992.	NULL
c-fos	NULL
proto-oncogene	NULL
expression	NULL
in	NULL
bronchial	NULL
biopsies	NULL
of	NULL
asthmatics	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

7:128-133	NULL
.	NULL

31	NULL
.	NULL

Adcock	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
Lane	NULL
,	NULL
SJ	NULL
.	NULL

,	NULL
Brown	NULL
,	NULL
C.R	NULL
.	NULL

,	NULL
Lee	NULL
,	NULL
TH	NULL
.	NULL

,	NULL
and	NULL
Barnes	NULL
,	NULL
PJ	NULL
.	NULL

1995	NULL
.	NULL

Abnormal	NULL
glucocorticoid	NULL
receptor-activator	NULL
protein	NULL
1	NULL
interaction	NULL
in	NULL
steroid-resistant	NULL
asthma	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1951-1958	NULL
.	NULL

32	NULL
.	NULL

Guo	NULL
,	NULL
FH	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Interferon	NULL
Y	NULL
and	NULL
interleukin	NULL
4	NULL
stimulate	NULL
prolonged	NULL
expression	NULL
of	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
human	NULL
airway	NULL
epithelium	NULL
through	NULL
synthesis	NULL
of	NULL
soluble	NULL
mediators	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:829-838	NULL
.	NULL

33	NULL
.	NULL

Kamijo	NULL
,	NULL
R.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
for	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
in	NULL
NO	NULL
synthase	NULL
induction	NULL
in	NULL
macrophages	NULL
.	NULL

Science	NULL
.	NULL

263:1612-1615	NULL
.	NULL

34	NULL
.	NULL

Hamid	NULL
,	NULL
Q.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
asthma	NULL
.	NULL

Lancet	NULL
.	NULL

342:1510-1513	NULL
.	NULL

35	NULL
.	NULL

Su	NULL
,	NULL
W.-C.S	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
Stat1	NULL
by	NULL
mutant	NULL
fibroblast	NULL
growth-factor	NULL
receptor	NULL
in	NULL
thanatophoric	NULL
dysplasia	NULL
type	NULL
II	NULL
dwarfism	NULL
.	NULL

Nature	NULL
.	NULL

386:288-292	NULL
.	NULL

36	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
Liao	NULL
,	NULL
J.Y	NULL
.	NULL

,	NULL
and	NULL
Song	NULL
,	NULL
M.M	NULL
.	NULL

1996	NULL
.	NULL

Enhancement	NULL
of	NULL
antiprolif-erative	NULL
activity	NULL
of	NULL
garnma	NULL
interferon	NULL
by	NULL
the	NULL
specific	NULL
inhibition	NULL
of	NULL
tyrosine	NULL
dephosphorylation	NULL
of	NULL
Stat1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4932-4941	NULL
.	NULL

37	NULL
.	NULL

Millet	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
inhibits	NULL
major	NULL
histo-compatibility	NULL
complex	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
disruption	NULL
of	NULL
the	NULL
Jak/Stat	NULL
pathway	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:675-683	NULL
.	NULL

38	NULL
.	NULL

Mishkin	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
Abrams	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
Goatley	NULL
,	NULL
LC	NULL
.	NULL

,	NULL
and	NULL
Dixon	NULL
,	NULL
LK	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
viral	NULL
mechanism	NULL
for	NULL
inhibition	NULL
of	NULL
cellular	NULL
phosphatase	NULL
calcineurin	NULL
.	NULL

Science	NULL
.	NULL

281:562-565	NULL
.	NULL

39	NULL
.	NULL

Koga	NULL
,	NULL
T.	NULL
,	NULL
Look	NULL
,	NULL
D.C.	NULL
,	NULL
Tidwell	NULL
,	NULL
RM	NULL
.	NULL

,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.J.	NULL
1998	NULL
.	NULL

Mechanisms	NULL
for	NULL
cytokine	NULL
regulation	NULL
of	NULL
B-chemokine	NULL
expression	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

157	NULL
:	NULL
A744	NULL
.	NULL

(	NULL
Abstr	NULL
.	NULL
)	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
May	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number9	NULL
1361	NULL

